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                                               ABSTRACT
Introduction;
Dengue has become a major international public health problem due to human morbidity and 
mortality it causes. The disease presents as acute febrile illness with chills, headache, retro-
oular pain, body aches and arthralgia in more than 90% of apparent cases accompanied by 
nausea, vomiting and a maculopapular rash resembling measles. . Aedes aegyptyi is the 
primary vector mosquito.  Dengue virus is a positive stranded encapsulated, RNA virus. . 
Dengue NS1 antigen has been detected in the serum of DEN virus infected patients as early 
as one day of onset of symptoms. In this study the potential use of dengue NS1 antigen and 
IgM and IgG antibodies in early dengue diagnosis has been analysed.
Materials and methods;
The study group consists of all febrile patients with fever of duration less than 5 days 
attending the medical OPD for a period of one year from July 2013. A totalof 176 blood 
samples from fever patients were received in the Microbiology lab in our instituition . Each 
sample was subjected to an immunochromatographic test  (card test ) for NS1 antigen , IgM 
and IgG antibodies . This was followed by ELISA for NS1 antigen, IgM and IgG antibodies. 
The other parameters such as age , duration of fever, gender and platelet count were also 
recorded.
Results;
Out of 176 samples tested , 57 (32%) were positive only for NS1 antigen, 7 (4%) samples 
were found to be positive for IgM antibodies and none was found to be positive for IgG 
antibodies by immunochromatographic test . The 57 samples which were found to be positive 
by NS1 ELISA were also found to be positive by immunochromatographic test. By ELISA 
method 37 samples (21%) were positive for IgM and 7 samples (4%) were found to be 
positive for IgG . Out 57 cases positive for NS1 antigen ,thrombocytopenia was evident in 42 
cases (74%) .In antibody positive cases  thrombocytopenia was noted in 20 out of 44 cases 
(45%).
Conclusion;
NS1 antigen detection is a useful tool in the early diagnosis of dengue infection and deserves 
inclusion in the diagnostic algorithm for suspected dengue fever cases .The results of NS1 
antigen ELISA is comparable to that of NS1 antigen ELISA .But in case of antibodies the 
immunochromatographic test is inferior to that of ELISA.
Key words : Dengue, NS1 antigen, IgM &IgG antibodies, platelet,
immunochromatographic test, ELISA,Early detection of dengue virus.
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INTRODUCTION 
 Dengue virus which is found mainly in the tropical and subtropical regions 
worldwide belongs to family  Flaviviridae . Dengue fever is an acute, potentially fatal 
viral infection that is endemic throughout India1.  According to the Oxford English 
Dictionary, the term dengue originated in the Swahili phrase " ka dinga  pepo '' (a 
kind of sudden cramp like seizures from an evil spirit or plague).  Dr. James 
Cahristies (1872) proposed that the disease crossed from East Africa to the Caribbean 
in18272. 
 The dengue virus originated in the forests, evolving from the mosquito virus to 
one capable  of causing disease in  humans. Deforestation by humans had helped the 
dengue virus to move out of the  out of the jungle to the rural environment3. As a 
result of economic development, people began to move out of rural areas to cities 
which also introduced dengue virus into a new environment. Transmission of dengue 
virus in Asia is maintained by a native mosquito species , the Aedes albopticus. When 
the virus was introduced into an  area that had become infested with the Aedes 
aegypti mosquito ,  dengue epidemics occurred .  Now there is evidence that both 
dengue virus and its primary vector, the Aedes   aegypti mosquito had their origins in 
either Asia or Africa4. 
 The first recorded case of dengue fever was documented from a Chinese 
medical encyclopaedia from the Jin Dynasty (265 -420 AD). The Chinese referred to 
a water poison associated with flying insects.  The first definitive case was reported in 
1789 and was attributed to Benjamin Rush, who also coined the term break bone fever 
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for dengue fever because of the symptoms of muscle and joint pain .The viral etiology 
and the transmission by the mosquitoes was deciphered only by 20th century. A 
pandemic of dengue infections began in Southeast Asia after  the end of World War II 
and then it spreaded around the globe2. 
 It is seen that global prevalence of Dengue infections has grown dramatically 
in recent years. According to WHO estimates dengue viral infections are responsible 
for hundred million cases of dengue infections annually and more than five lakh cases 
of dengue haemorrhagic fever5. The main factors which had made dengue infections a 
global health problem is unprecedented global population growth, unplanned and 
uncontrolled urbanisation and deterioration in water, sewer and waste management 
systems4. The emerging dengue viral infections is of great threat to the mankind as 
there is no specific medication available nor there is any vaccine available against 
dengue virus.6 
 Dengue virus consists of four distinct serotypes based on their antigens, 
namely DENV1, DENV2, DENV3 and DENV4. All the four serotypes of Dengue 
virus (which are closely related) is distinguished by both serology and molecular 
diagnostic methods. Currently, five subtypes have been identified for DEN-1, six 
subtypes for DEN-2, four subtypes for DEN-3 and two subtypes for DEN-4. Dengue 
virus consists of a positive stranded, encapsulated RNA as their genetic material 
which is 11kb long and has a single open reading frame (ORF) which codes for a 
single polypeptide. This polypeptide consists of three structural proteins and seven 
non-structural proteins. The structural proteins are named as core protein C, 
membrane protein M and envelope protein E. The seven non structural proteins are 
NS1, NS2A , NS2B , NS3 , NS4A, NS4B and NS5 .7 
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 NS1 protein is a 50 kilodalton glycoprotein (353 or 354 amino acids), which is 
expressed on the surface of cells infected with dengue virus. It is produced in both 
membrane associated and secreted forms 8.  Several studies conducted revealed that 
NS1 can be detected in the blood of dengue virus infected patients even before the 
detection of antibodies9. It may be detected in the blood from the first day of fever up 
to the fifth  day of fever which is the critical period of illness preceding defervescence 
which generally occurs by the fifth day10,11. Therefore commercial diagnostic kits 
have utilised virus coded NS1 antigen as a basis for early detection of dengue viral 
infections12. Currently, NS1 antigen captures ELISA and rapid 
immunochromatographic tests are available for detection of NS1 antigen. Detection of 
Dengue NS1 antigen presents a better method for the early diagnosis of dengue viral 
infections1. A positive NS1 antigen test may confirm a dengue infection. The 
antibodies for dengue infections remains undetectable for months and a positive result 
obtained on a single blood specimen cannot rule out dengue viral infection5. 
           The antibody production following Dengue viral infection consists of IgM and 
IgG antibodies which are produced against the viral envelope proteins. The type of 
antibody production may depend on whether an individual has a primary dengue viral 
infection or a secondary dengue viral infection11. In primary dengue viral infection the 
individual may be exposed to dengue or other flavivirus infection for the first time 
where as in secondary infection the individual had dengue or any other flavivirus 
infections in the past12.  In general, dengue diagnosis depends on the infection phase. 
A primary dengue viral infection is characterised by a low titre antibody production.   
The first immunoglobulin isotype to appear in primary dengue infection is IgM . IgM 
antibodies may be detectable approximately 3 to 5 days after the onset of fever and 
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then its levels increases rapidly and peaks for 2 weeks after the onset of fever. 
However IgG immunoglobulins are detectable at low titres by the end first week of 
illness and then it rises slowly.  The level of IgG  antibodies decline  slowly  over the 
next 3 to 6 months8. 
          Dengue virus is transmitted through human – mosquito cycle by Aedes aegypti 
mosquito. The extrinsic incubation period is 8 – 10 days13. Dengue fever has an 
incubation period of 5-11 days after which the patient presents with fever of sudden 
onset with headache, retrobulbar pain, conjunctival injection, pain in back and limbs 
(break- bone fever), lymphadenopathy and maculopapular rash. The fever is typically 
biphasic (saddle – back) and it may last for five to seven days14.  
          Dengue infections can also occur in serious forms with haemorrhagic symptoms 
known as dengue haemorrhagic fever or with shock known as dengue shock 
syndrome2. This may be due to hypersensitivity reaction to sequential dengue virus 
infections in persons sensitised by prior exposure to other serotypes of virus .High 
levels of early NS1 antigens in the blood may be associated with more severe clinical 
manifestations15. 
 The Aedes mosquito bites mainly during the day time with increased biting 
activity two hours after the sunrise  and several hours before sunset, and it feeds itself 
in the dark corners of the houses or on hanging objects like clothes, umbrella or under 
the furniture16. Aedes aegypti mosquito can breed in any type of containers having  
very small quantity of water. Eggs of Aedes aegypti can survive without water for 
almost a year. The favourite breeding habitats are coolers, buckets, cups, broken pots, 
flower vases, plant saucers , tanks, cisterns, bottles, tins, tyres, coconut shells, tree 
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holes and many other places where rain water can be collected or stored .  So vector 
control is the most efficient way of controlling dengue fever17. The best way to 
control mosquitoes is to control of mosquito egg laying site by simple measures like 
adding drainage holes to structures and containers that may trap water (barrels, old 
tyre). Thin out weeds and remove old leaves from pond , this will allow natural 
mosquito eating fish to access areas where mosquitoes lay their eggs .The use of 
pesticides should only be supplemental to controlling mosquitoes through the 
reduction and management of mosquito egg laying areas 18. Bacillus thuringiensis 
serotype H-14   and Bacillus sphaericus can be used as effective mosquito control 
agents19. Larvivorus fish (Gambusia affinis and Poecilia reticulate) can also be 
introduced for the control of Aedes mosquitoes in large water containers .Another 
method for protection against mosquito bite is personal protection by wearing long 
pants and long sleeves to cover the skin. Repellents with DEET (N, N – dimethyl –
Meta-toluamide) are the most effective18. A well documented phenomenon reported 
from many parts of the dengue endemic area is transovarial transmission of dengue 
virus in aedes mosquito, which further emphasized the importance of the larval 
control since the larval stages has become the reservoir of the dengue virus in the 
inter-epidemic period.20 
 In this study, the potential use of dengue NS1 antigen in early dengue 
diagnosis is analysed and compared to the current antibody methods available in our 
laboratory. 
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DENGUE CASE DEFINITIONS21, 22; 
[2009 NEW DENGUE CASE DEFINITIONS] 
Dengue without any warning signs ; 
Fever and any two of the following:   
1) Nausea ,vomiting 
2) Rash on the body 
3) BodyAches and joint pains 
4) Leukopenia 
5) Positive tourniquet test. 
Dengue with warning signs  
Dengue as defined above with any of the following : 
1)  Pain in the abdomen 
2) Persistent vomiting 
3)  Fluid accumulation anywhere in the body ( ascites, pleural effusion ) 
4) Bleeding from the mucosa 
5) Weakness, restlessness. 
6) Liver enlargement more than 2 cm. 
Laboratory:  increase in HCT concurrent with rapid decrease in platelet count  
**Requires strict observation and medical care. 
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SEVERE  DENGUE; 
Dengue with at least one of the following criteria : 
•  Severe Plasma Leakage leading to: 
¾ Shock ( Dengue Shock Syndrome). 
¾ Fluid accumulation anywhere in the body with respiratory 
distress. 
• Severe Bleeding as evaluated by clinician 
• Severe organ involvement 
¾ Liver: AST or ALT more than equal to1000. 
¾ Central nervous system: altered consciousness. 
¾ Failure of heart and other organs. 
 The real WHO classification is defined as follow: Dengue Fever (DF), Dengue 
Haemorrhagic Fever (DHF), and Dengue Shock Syndrome (DSS). 
1997 DENGUE CASE DEFINITIONS; 
DENGUE  FEVER  : 
 Dengue fever is most commonly an acute febrile illness defined by the 
presence of fever and two or more of the following, retro-orbital or ocular pain, 
headache, rash, muscle pain, joint pain, leucopoenia, or haemorrhagic manifestations  
(eg, positive tourniquet test, petechiae, purpura/ecchymosis, bleeding from the gums 
or nose, blood in vomitus , urine or stool or vaginal bleeding) but not meeting the case 
definition of dengue haemorrhagic fever.  Anorexia, nausea, abdominal pain , and 
persistent vomiting may also occur but are not case defining criteria for dengue fever. 
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DENGUE HAEMORRHAGIC FEVER 
•  Fever lasting from 2—7 days. 
• Evidence of haemorrhagic manifestation or a positive tourniquet test. 
• Thrombocytopenia ( < /=100,000 cells /mm3) 
• Evidence of plasma leakage as shown by haemoconcenteration ( an increase in 
haematocrit >/=20%  above average for age or a decrease in haematocrit 
>/=20 % of baseline following fluid replacement therapy), or pleural effusion, 
or ascites or hypoproteinemia. 
DENGUE SHOCK SYNDROME  
 DSS has all the criteria of Dengue haemorrhagic fever plus circulatory failure 
as evidenced by; 
• Rapid and weak pulse  and narrow pulse pressure (<20 mm Hg ) , or 
• Age –specific hypotension and cold , clammy skin and restlessness . 
EPIDEMIOLOGY OF DENGUE INFECTIONS 
 The Centre for Disease control has been the primary source of information 
about the world wide distribution of dengue viral infection .Global incidence of 
dengue infections during 2010 is rising at the highest rate since 1988. Dengue viral 
infections have been epidemic in tropical and sub-tropical areas which were 
previously considered as non-endemic to dengue virus.  The main areas are Asia, 
Americas, and the Caribbean .  Typically transmission of dengue virus peaks near the 
equator during the annual rainy season. There are reports that epidemics for dengue in 
India and Southeast Asia (like, Indonesia, Sri Lanka, Taiwan, and Thailand) started up 
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to 4 weeks earlier than normal time, which is mainly due to heavy and prolonged 
rainfalls. .Among the Central and South American countries, epidemics have been 
declared in Peru, Venezuela, Colombia, Brazil, Nicaragua, Honduras, and Paraguay. 
The Dominican Republic has been declared a state of emergency because of 
alarmingly high case fatalities from dengue fever. A number of areas where dengue 
has been absent or rare during the 21st century have reported cases, including 
Australia, Nepal, Jeddah, Saudi Arabia, Reunion Island, Comoros, Tanzania and 
Senegal. 
 Since India is endemic to dengue virus, it is very important to study the 
epidemiology of dengue in India. The first major dengue epidemic occurred in 
Chennai in 1780’s which later spread all over the country 23. Dengue virus was first 
isolated in Japan in 1943 but the one which was isolated from Calcutta in 1944 from 
the blood of the US soldiers had been considered as the first report for dengue virus 
infection for a long time. When the first epidemic of Dengue haemorrhagic fever 
occurred during 1996 in Northern India, nothing was known about its emergence. 
Dengue type 2 viruses were responsible for 1996 epidemics, while the 2003 
epidemics were mainly due to dengue type 3 viruses. All the four serotypes of dengue 
virus have been isolated from India. The first major outbreak of dengue fever in India 
was reported from Calcutta in 196424 followed by an epidemic in Vishakhapatnam in 
1965 25. Delhi had outbreaks of dengue viral infections due to different dengue 
serotypes in 1967, 1970, 1982, and 1988. 
 Isolates from these different (geographically distant) epidemics are closely 
related and belong to DV-3 subtype III, which initially originated in the India. The 
emergence of Dengue haemorrhagic fever in Sri Lanka in 1989 coincided with the 
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appearance of a new dengue virus3, subtype III variant.  This variant spreaded from 
the Indian subcontinent to Africa in 1980 and fro Africa to Latin America in the mid 
1990. DV3 subtype III isolates from the mild and severe disease outbreaks form 
genetically distinct groups which suggested a role of viral genetics in Dengue 
haemorrhagic fever.26 
 Cases of DHF were reported for the first time in 198827. Although several 
cases of dengue viral infections occurred in India, only occasional cases of DHF/DSS 
have been reported. This is rather puzzling because DHF has been very common in 
South East Asia but rare in the India despite presence of all  four serotypes in both 
regions . Epidemiological studies have shown that the rate of the virus transmission 
and the amount of each dengue serotypes, remained constant before the emergence of 
dengue haemorrhagic fevers. The incidence of DHF from 1989 in the Indian sub 
continent was correlated with the introduction of a new subtype DEN -3 subtype III. It 
is the predominant one which is genetically distinct from DEN3 previously isolated 
from the infected persons presenting with severe disease and are inherently more 
virulent28.  
 After 1989, frequent epidemics of DHF occurred in several countries of the 
Indian subcontinent. DF and DHF have been reported from Coimbatore, Erode in 
199829. Another outbreak occurred in Mangalore in 199330. After a gap of eight years 
a large outbreak of dengue fever of serious nature occurred in Delhi again in 1996. 
The cause was confirmed as dengue virus type 2 subtype III by virus cultivation and 
direct immunofluorescence with monoclonal antibodies31. During the outbreak from 
August to November, a total of 10,252   cases and 423 deaths have been reported to 
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the State Directorate.  Delhi, Haryana, Rajasthan, Karnataka and Tamil Nadu have 
reported dengue in small numbers in 1998 , 1999 , 200032.   
 The major dengue outbreak in North India caused by dengue virus type3 
subtype III occurred  in 2003 and 2004 .  The re-emergence of  fatal subtype III of 
DEN -3 which replaced  the earlier circulating subtype 1V of DEN-2 in India is a 
matter of concern33. An outbreak of Dengue haemorrhagic fever and dengue shock 
syndrome occurred in  Delhi in 2006. This is the first report from India with high 
percentage of concurrent infections with different dengue virus serotypes circulating  
during one outbreak 34. 
Epidemiology of Dengue in Tamil Nadu; 
 Statistics from the National Vector Borne Disease Control Programme 
(NVBDCP) show that the state recorded 677 cases after Maharashtra (963) and was 
followed by Kerala (651). According to experts, in the state’s rural area , acute water 
shortages forces people to store water in vessels that help breed mosquitoes. Dengue 
virus serotypes 2 and 3 are mainly found in this regions.35 
PATHOGENESIS OF DENGUE FEVER 
 After an infectious mosquito bite,virus which replicates in local lymph nodes 
and disseminates via blood to various tissues within the next 2-3 days. Virus 
circulates in infected monocytes and macrophages and to a lesser degree in B and T 
cells for 5 days. It also replicates in skin, reactive spleen, lymphoid cells and 
macrophages. 
 In liver viral antigen can be demonstrated in Kuppfer cells and endothelia. 
Changes occurring in liver include hypertrophy of kupffer cells, focal ballooning and 
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necrosis of hepatocytes with occasional Councilman Body formation. Skin rashes 
comprise lymphocytic dermal vasculitis and viral antigen. Malaise and flu like 
symptoms reflect cytokine response. Myalgia is due to moderate perivascular 
mononuclear infiltrate with lipid accumulation37. 
 Central nervous system abnormalities can be attributed to metabolic 
alterations, haemorrhagic manifestations, viral CNS invasion and encephalitis. Shock 
ensues when there are sudden extravasations of plasma into the extra vascular sites 
including pleural and abdominal cavities usually with defervescence of fever. Dengue 
virus NS1 protein or the antibodies to dengue infection  might  interact  with 
glycocalyx layer of endothelium in such a way as to alter temporarily the 
characteristics of the fibre matrix which may contribute to the increased permeability 
of the endothelium . Enhanced fibrinolytic activity develops due to the interaction 
between viral particle and plasminogen. Release of Heparin sulphate or Chondroitin 
sulphate from endothelial membrane also contributes to the mechanism. Procoagulant 
markers are increased to some degree with a decrease in anticoagulant proteins38. 
 Dominant epitopes that react with antigen responsive T lymphocytes are 
peptides of the dengue non structural protein NS3. During secondary infections 
expansion of lower avidity memory T cells takes precedence over that of the naive T 
cells with higher avidity for the new DEN-5 serotype. CD8+T cells generated during 
infection binds weakly to the MHC tetramers presenting epitopes of the infecting 
virus. A frequency of these cells shows an apoptotic phenotype and seems destined to 
die before  the infection is adequateycontrolled. Low avidity T cells that dominate the 
response to secondary infection are less optimally efficient at elimination of dengue 
virus infected cells . Infants in endemic areas fail to develop dengue infection till 6 
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months due to presence of broadly reactive dengue neutralizing  antibodies  in their 
mother‘s serum and the protection being passively transferred passively by maternal 
antibodies.  Here Dengue haemorrhagic fever is explained by enhancing antibodies 
which leads to an increase in cell mass which is infected. T cell and cytokine response 
are proportional to this antigenic stimulus. Evidence suggests that antibody dependant 
enhancement results from idiosyncratic Fc  receptor  signalling . Resulting production  
of  IL-2 ,  interferon’s  and other lymphokines  is reinforced  by increased  abundance 
of  infected  target cells resulting from interferon mediated upregulation  of Fc 
receptors  and Flaviviral  induced expression of MHC type 1 and 2 molecules  that  
further   activate  T lymphocytes . Activated infected   monocytes  produce and 
release  TNF alpha , IL-1, Platelet Activating Factor ,  IL-8 , and  RANTES  which 
synergistically with lymphokines ,  histamines , and viral immune complex induces 
C3a and C5a to produce the temporary endothelial  dysfunction  that leads to plasma 
leakage . After binding to cells, DENV- NS1 antigen  induces apoptosis of cells  
which is mediated by NO.   NS1   can activate complement by alternate pathway. The 
chief abnormality observed in and around small blood vessels  consisting of 
endothelial swelling, perivascular edema and infiltration with mononuclear cells. 
Cytotoxic factor is a unique pathogenesis associated cytokine in mice and humans 
seen during dengue virus infections. 39  
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AIMS AND OBJECTIVES 
 
1) Importance of NS1 antigen in early detection of dengue fever. 
2) Role of IgM/IgG antibody detection in dengue diagnosis. 
3) Importance of looking for all three parameters, NS1 antigen, IgM/IgG 
antibodies in dengue diagnosis. 
4) Level of NS1 antigen and severity of dengue fever. 
5) Relationship of thrombocytopenia and dengue markers. 
6) Comparing Immunochromatographic test and ELISA in the detection of NS1 
antigen, IgM/IgG antibodies. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Review  of Literature 
 
Review of Literature 
 15 
 
REVIEW OF LITERATURE 
 
¾  In 1978, Igarashi A performed virus isolation by inoculation into C6/36 Aedes 
albopticus cell line41. 
¾ In 1980, David prepared monoclonal antibodies specific for dengue virus type 3. 
Mouse lymphocyte hybridomas was prepared by polyethylene glycol – mediated 
fusion of cells from a mouse plasmocytoma cell line with lymphocytes from a 
mouse which was hyperimmunised with dengue virus type 3. Media from 50 
hybrid colonies was screened; out of which 46 of them showed antibody activity 
against dengue -3 infected cells as determined by an indirect immunofluorescent 
antibody technique. Dengue monoclonal antibody which was obtained after 
cloning one of these colonies  also demonstrated activities in haemagglutination 
inhibition and indirect immuofluorescent antibody assays with dengue 3 antigen, 
but not with type 1, 2 or 4 antigens. In addition, this antibody activity could be 
removed from the culture media only by absorption with dengue -3 antigen42. 
¾ In 1981, Churdboonchart et al for the first time quantified dengue precipitating 
antibody by a method of inhibition counter current immunoelectrophoresis. This 
test was also employed to detect dengue virus antibody in patient sera. Anti-
dengue type 2 titres determined by inhibition countercurrent 
immunoelectrophoresis were correlated well with haemagglutination inhibition 
titres. In secondary cases, more than fourfold increases in precipitating 
antibodies were observed. The control sera were negative except for sera from a 
few patients with systemic lupus erythematosus, which had shown low titres. 
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Simultaneous detection of dengue virus antigen and antibody in the sera 
collected during acute phase can confirm at least 90% cases. This method was 
recommended as a routine technique to quantitate antibody in sera from 
suspected cases of dengue haemorrhagic fever43.  
¾ In 1983, Burke had reported the serotype specificity of IgM antibody  to dengue 
virus by IgM capture immunoassay with a convalescent –phase serum of four 
serotypes of dengue virus antigen. He found that serotype specific IgM antibody 
responses corresponding to the dengue virus type isolated from all the sixteen 
primary infection patients but only in nine out of sixteen secondary infection 
patients44. 
¾ In 1984, Gubler D J and Kuno G identified virus isolates by indirect fluorescent 
microscopy (IFAT) using serotype- specific monoclonal antibodies45. 
¾ In 1986 Rice had observed that dengue viral RNA gene is 5’  capped and it does 
not have a poly (A) tail and is translated from a single open reading frame to 
yield a polyprotien which consists of three structural proteins ( core protein C, 
membrane protein M , and Envelope protein E ) followed by seven non 
structural proteins ( NS1 , NS2A, NS2B, NS3 , NS4A , NS4B , NS5 )46. 
¾ In 1989, Winkler etal observed that Dengue NS1 antigen which is a highly 
conserved 46 kDa  non structural glycoprotein   exists  as an intracellular  
membrane – associated form and as an extracellular secreted form in the dengue 
virus infected mammalian cells47 . 
¾ In 1991 Kuno etal had observed that dengue serology faced with some problems 
of a small percentage of secondary dengue infected samples with low or no 
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detectable dengue IgM. Thus a surveillance system that relied on IgM detection 
alone is not likely to reflect the transmission dynamics of the disease48. 
¾ In 1992, Blok J etal said that NS1 protein is a 50 kDa glycoprotein which also 
had similarity among other Flavivirus49. 
¾ In 1993, Thien et al said that the sera from patients in the acute phase of dengue 
haemorrhagic fever or dengue shock syndrome (DSS) contained higher levels of 
anti-dengue antibodies of the IgG1, complement fixing, and subclass than 
similar sera from dengue fever (DF) patients. Conversely, acute phase sera from 
DHF and DSS patients also contained lower levels of anti-dengue antibodies of 
the poor complement activating IgG2 subclass than acute phase sera from DF 
patients. No significant differences were detected between the levels of anti-
dengue IgG3 and IgG4 antibody in acute phase sera from DF, DHF, and DSS 
patients .With the exception of levels of levels of anti-dengue IgG2 antibody 
from DHF patients which were lower than those from DF and DSS patients, 
levels of anti dengue IgG1, IgG2, IgG3 and IgG4 were similar in convalescent 
sera from all the patients. These results had provided a possible explanation for 
the activation of the serum complement system which precedes onset of shock 
in severe dengue infections50. 
¾ In 1995, Sonali etal did a study on antibody – enhanced binding of Dengue -2 
virus to human platelets. The mechanism underlying severe thrombocytopenia 
in dengue haemorrhagic fever /dengue shock syndrome was not completely 
understood. Dengue 2 virus binded to human platelets only in presence of virus-
specific antibody, supporting a role for immune –mediated clearance of platelets 
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in the pathogenesis of thrombocytopenia in DHF/DSS.  Antibody enhanced 
binding of virus to the platelets was also demonstrated with a panel of eight 
murine monoclonal antibodies which was specific for dengue protein 51.  
¾ In 1996, Monath and Heonz had observed that Dengue NS1 antigen can be 
detected in the circulation during dengue virus infection and it elicits a specific 
immune response52. 
¾ In 1996, Mackenzie etal suggested that the function of NS1 antigen in dengue 
viral replication is not clear. He concluded that NS1 antigen can also serve to 
anchor the replication complex to the endoplasmic reticulum membrane53. 
¾ In 1998 Pie-Yun Shu etal  had developed envelope and membrane [E/M]  non 
structural protein NS1 serotype –specific capture IgM ELISAs to differentiate 
four dengue virus serotypes . A total of 93 anti- dengue virus IgM –positive 
serum samples were collected between day 5 and 45 of illness from 59 
confirmed dengue patients were analysed . The results showed that positive 
serotype specificity could be identified for 86.1 % and 47.6% of serum samples 
tested for E/M – specific IgM antibodies versus 83.3 % and 42.9% of serum 
samples tested for NS1 – specific IgM antibodies from patients with primary 
and secondary dengue infection ,respectively . Dual analysis with both E/M and 
NS1 serotype – specific capture IgM  ELISAs had shown that positive serotype 
specificity could be correctly identified for 98.6 % and 61.9%of all the primary 
and secondary serum samples tested , respectively . These findings suggested 
that E/M and NS1 serotype – specific capture IgM ELISAs have the  potential to 
be of use in dengue virus serotyping54. 
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¾ In1998, Andrea et al  had detected dengue antibodies in saliva during dengue 
infection . Saliva sample was collected prospectively from patients presenting 
with suspected dengue infection 4 to 8 days after the onset of fever and assayed 
using a commercial dengue IgM and IgG ELISA. Laboratory diagnosis was 
based on virus isolation and on haemagglutination inhibition assay. With a 
positive result defined as either salivary IgM or IgG levels above the cut-off 
value, an overall sensitivity of 92 % was obtained for both primary and 
secondary dengue patients, while no patients with non-flavivirus infection and 
no healthy laboratory donors showed the elevation of salivary anti-dengue 
antibody. Salivary IgG levels correlated well with the serum Haemagglutination 
titre and the salivary IgG levels which can be used to distinguish between 
primary and secondary dengue virus infection55.  
¾ In 1999, Araujo ESM etal   observed a more than fourfold rise in IgG antibody 
titre against dengue virus by ELISA between  acute and convalescent sera 
samples56. 
¾ In 2000, Michel Strobel had described 2 patients with autoimmune  
thrombocytopenic  disease who also developed classic dengue fever associated 
with serious bleeding and extremely low platelet counts ( 1000 cells/mm3  3000 
cells /mm3  respectively ). These cases had illustrated that the large, harmful and 
misleading decrease in the platelet count that may be a result of common dengue 
fever occurring in individuals who co-incidentally have underlying 
Thrombocytopenic purpura. This situation was not unique, because there are 
other examples of viral infection which can seriously destabilize chronic 
cytopenic diseased conditions such as Parvovirus B19 infection in humans, that 
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cause  severe erythroblastopenic anaemia in patients having haemolytic anaemia 
. Because both patients were adults who used to live in dengue endemic area, 
they presumably had secondary dengue fever. First, classic dengue fever can 
induce marked thrombocytopenia in up to 50% healthy subjects with a platelet 
count that is sometimes as low as 10,000 platelets /mm3; this feature could not 
lead to misclassification. Because of air travel becoming more popular these 
days, emerging dengue fever could not be overlooked. Although Dengue fever 
may be  benign in a large number of healthy subjects, presence of the disease 
may be of concern in subjects with chronic TCP a relatively common 
condition18. 
¾ In 2000, Koraka etal had compared  the diagnostic value of immune- complex 
NS1 antigen dot blot immunoassay (DBI )  to a commercially available DEN 
antigen detection kit  and confirmed it with a reverse transcription PCR kit (RT-
PCR). 181 serum samples which were obtained from 55 acute dengue virus 
infected patients was used . From 32 out of 55 dengue patients, viral RNA could 
be detected by RT PCR. DEN antigen was detected to in only 10 out of 55 
patient samples. When these samples were treated with acid release the immune 
complex associated NS1 antigen for detection by DBI, 43 out of 55 patients 
were found to be positive dengue NS1 antigen . In non-dissociated samples 22 
of these patients were found to be positive by DBI57. 
¾ In 2000, Young etal had observed that an antigen capture ELISA reveals high 
levels of dengue virus protein NS1 in the sera of infected patients. This study 
describes the development of a capture enzyme linked immunosorbent assay for 
the detection of the dengue virus non-structural, NS1 protein. The assay 
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employs rabbit monoclonal and polyclonal antibodies as the detection and 
capture antibodies respectively. Immuno affinity –purified NS1 derived from 
dengue 2 virus–infected cells was used as a standard to establish a detection 
sensitivity of approximately 4 ng/ml for an assay employing monoclonal 
antibodies recognising a dengue2 serotype–specific epitope. A number of 
serotype cross-reactive monoclonal antibodies were also shown to be suitable 
probes for the detection of NS1 expressed by the remaining three dengue virus 
serotypes. Examination of clinical  samples demonstrated that the assay was 
able to detect NS1 with minimal interference  from the serum components at the 
test dilutions routinely used , suggesting that it could form the basis of a useful 
additional diagnostic test for dengue virus infection . The quantitation of NS1 
levels in the patient sera may prove to be a valuable surrogate marker for 
viraemia58.  
¾ In 2001 , Kurane. I demonstrated that the anti-NS1 antibodies are mainly formed 
during secondary dengue viral infections in patients from Indonesia ( where 
dengue haemorrhagic fever is more common than in patients from Caribbean 
where dengue haemorrhagic fever is less common ). These pre-existing anti-
NS1 antibodies possibly result from the formation of antigen –antibody immune 
complexes and therefore reduce the sensitivity of DEN NS1 antigen detection 
assay22.  
¾ In 2002, Libraty etal observed that an increased levels  of NS1 antigen were 
formed within 72  hours of illness, which identified the patients at risk of 
developing dengue haemorrhagic fever , through  the quantitative estimation of 
NS1 antigen were not carried out in this study to confirm the diagnosis59. 
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¾ In 2002 Chow etal had suggested that NS1 antigen detected in 82% to 83% of 
dengue patients from the first day of fever up to the ninth day  from the onset of 
fever60. 
¾ In 2002 et al Wang et al detected replication of dengue virus  in the peripheral 
blood mononuclear cells from dengue virus type 2 –infected patients by a 
reverse transcription– real– time PCR assay. While dengue virus is thought to 
replicate in mononuclear phagocytic cells in vivo, attempts had been done to 
detect it in peripheral blood mononuclear cells (PBMC) by virus isolation or 
antigen detection have had variable and generally low rates. In this study,  a 
reverse transcription (RT)- real time PCR assay was developed to quantify 
positive – and  negative –sense RNA of dengue virus type 2 within the cells . 
The assay includes an RT step using either sense or antisense primer followed 
by a real –time PCR step using the designed primers and probe , which could 
target a capsid region which is highly conserved in dengue virus type 2 strains . 
It can be used to monitor the dynamic change of intracellular dengue virus RNA 
species during the course of infection.  When this assay is employed in 
quantification of dengue virus RNA species in PBMC from 10 patients infected 
with dengue virus type 2, both positive and negative sense dengue RNA can be 
detected, indicating that dengue virus is actively replicating in PBMC in vivo. 
Moreover, the amounts of negative–sense dengue virus RNA in PBMC correlate 
very well with the viral load of dengue virus replication in vivo61. 
¾ In 2003, Koraka P etal , NS1 detection rate is higher in  patients with primary 
dengue than those with secondary dengue viral infections . A possible basis for 
reduced sensitivity in secondary infection is that NS1 along with other viral 
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antigens is sequestrated in immune complex when a substantial level of  the 
dengue viral reactive IgG is present57. 
¾ In 2003, Gubler had said that Dengue fever  which is mosquito borne viral 
disease affects approximately 50-100 million individuals yearly in more than 
hundred countries 62. 
¾ In 2002, Diana used recombinant antigens for differentiation of dengue virus 
serotype 1 to 4 by serology . The B domains of dengue virus serotypes 1 to 4 
were expressed in Escherichia coli. The purified proteins applied to immunoblot 
strips to detect serotype specific antibodies in paired serum samples from 41 
patients with primary and secondary dengue viral infections. A close correlation 
was found between the results obtained with the immunoblot strips and by type 
specific RT- PCR22 . 
¾ In 2002, Alcon etal had demonstrated that IgM ELISA, which is commonly used 
assay, has decreased sensitivity in the first 4 day of illness63. 
¾ In 2002, Twiddy investigated genetic diversity and phylogenetic relationships of 
a collection of strains of dengue virus type 1 (DV-1 ) isolated from different 
parts of the world. Phylogenetic trees derived from the complete sequence of the 
E gene of suggested the existence of five genetic types defined by the maximum 
nucleotide divergence within each group of 6%. The average rate of evolution 
was estimated to be approximately 16.2 x10-4 substitutions third codon position 
site year. Using this estimate, divergence among the DV-1 genotypes was 
calculated to have occurred approximately 100 years ago. Very low average 
value of the ratio of non-synonymous –to-synonymous nucleotide substitutions , 
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relative to the respective sites (0.046 ), indicated that the evolution of the E gene 
of the DV1is subject mostly to purifying selection . Nucleic acid sequence 
comparison revealed that the identify among the DEN-4 viruses was greater than 
92%. Similarly among deduced amino acids was between 96 and 100%; in most 
cases identical amino acid substitutions occurred among viruses from similar 
geographical regions. Recent dengue evolution in Puerto Rico can be attributed 
in part to positive selection on the non structural gene 2A (NS2A) whose 
function may include replication efficiency and antigenecity. During the latest 
and most severe DEN-4 epidemic in 1998, viruses were distinguished by three 
amino acid changes in NS2A that were fixed far faster than expected by drift 
alone . It therefore demonstrates viral genetic turnover within a focal population 
and the potential importance of adaptive evolution in viral epidemic expansion 
.A number of amino acid positions have been identified with the envelope (E) 
glycoprotein that is subjected to relatively weak positive selection in both DEN-
3 and DEN-4 , as well as in two genotypes of DEN-2 . No positive selection was 
detected in DEN-1 . In accordance with the function of the E protein as the 
major antigenic determinant of DEN, the majority of these sites were located in, 
or  near to, potential T- B- cell epitopes64. 
¾ In 2002, Woelk  etal Several positively selected  amino acid substitutions were  
also identified in the NS2B  and NS5 genes of DEN-2 , although the cause of 
this selection is unclear, whereas the capsid, membrane  and non-structural 
genes NS1 , NS2A , NS3 and NS4 were  all subjected to strong functional 
constraints . Hence, evidence was found for localized adaptive evolution in 
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natural isolates of DEN, revealing that selection pressures differ among 
serotypes , genotypes and viral proteins65 . 
¾ In 2002, Wang etal detected replication of dengue virus in peripheral blood 
mononuclear cells from Dengue virus type 2 infected patients by a reverse 
transcription – Real –Time PCR Assay.  While dengue virus is thought to 
replicate in mononuclear phagocytic cells in vivo, attempts to detect it in 
peripheral blood mononuclear cells (PBMC) by virus isolation or antigen 
detection have had variable and generally low rates. In this study, they 
developed a reverse transcription (RT) - real time PCR assay to quantify 
positive and negative sense of dengue virus type2 within the cells. The assay 
include an RT step using either sense or antisense primer followed by real time 
PCR using the designed of intracellular dengue virus RNA species during the 
course of illness61.  
¾ In 2002 and2003 Hua Xu etal had observed that  the rapid diagnosis and 
serotyping of dengue viral infections was important for timely diagnosis and 
management in areas where multiple flaviviruses was epidemic. A specific 
antigen captures ELISA for early detection and serotyping of dengue virus 
serotype1 by using well characterised monoclonal antibodies (MAbs ) specific 
to monoclonal antibodies specific to NS1 of dengue virus 1 was developed . 
With this assay 462 serum specimens from clinically probable dengue virus 1 
infected patients during dengue virus 1 epidemics in Guangdong, China in 2002 
and 2003 were analysed. Dengue virus NS1 was detectable in the blood 
circulation from the first day up to 18 days after the onset of symptoms with a 
peak at days 6 to 10. The sensitivity of DV1 NS1 detection in serum specimens 
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with reference to results from reverse transcriptase PCR was 82 % and the 
specificity was 98.9% with reference to 469 healthy donors66. 
¾ In 2004, Schilling S said that immune response in  primary dengue infection 
have been characterised by a slow and low titre of IgG antibody response. IgM 
antibodies appear only 3 to 5 days after the onset of the disease. Thus there is a 
transient window period of first few days of illness if antibody is used as a 
diagnostic test18.  
¾ In 2004, Wagennar said that Human leucocyte antigens (HLA ) expressed on the 
cell surface function as antigen presenting molecules and those polymorphism 
could change individual’s immune response . A study conducted in Viatnamese 
children had shown that persons carrying HLA-A*240203/10 are about 2 times 
more likely to have severe dengue infection than others. On the other hand, 
HLA-DRB*10901 persons are less likely to develop DSS with DEN-2 virus 
infection. These results clearly stated that HLA controlled the susceptibility to 
severe forms of dengue viral infections67. 
¾ In 2004 Pie-Yun Shu said that virus isolation from mosquitoes remained the 
gold standard although it has been replaced by RT-PCR for rapid. The dengue 
virus can be successfully detected by culture but viraemia is brief. Within a day 
or two after subsidence of fever, antibodies rise and further interfere with virus 
isolation. Dengue virus is thermolabile. Viral laboratories are expensive to 
develop and maintain and services  are not widely available .The common 
sample used for culture include serum, plasma, leukocytes washed of antibodies 
from patients; homogenised minced tissues eg, liver, lung , spleen, lymph nodes, 
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thymus, cerebrospinal fluid , serum and plasma as autopsy specimen. Early 
collection of sample, proper handling and prompt delivery to the laboratory 
leads to successful isolation of virus. Isolation may be done by inoculation into 
the thorax of mosquitoes belonging to Toxorhynchites spendens   or adult male 
mosquitoes of Aedes aegypti or Aedes albopticus . Although they were smaller 
in size, require more delicate inoculation technique, they have sensitivity equal 
to that of Toxorhynchites. Specimen may also be inoculated in any of the widely 
available mosquito cell lines (eg; C6/36, AP-61, Tra-284, AP-64 CLA-1 cell 
lines , and mammalian cell like LLCMK2, Vero and BHK21 ). This technique 
was slightly sensitive than inoculation in live mosquitoes. Culture in cell lines 
like VERO and in intracerebrally inoculated newborn mice is the least sensitive 
methods. Dengue type specific monoclonal antibodies are used to examine 
mosquito head squashes, infected cells, and infected cell culture fluids for 
identification. The binding of specific monoclonal antibody is revealed by a 
second labelled antibody (indirect fluorescent antibody test using serotype 
antibodies)68.Progress toward the detection of antigen in acute –phase serum 
samples by serology has been slow due to the low sensitivity of the assay for the 
patients with secondary infections, as such patients have pre-existing virus-
antibody immunocomplexes. However , recent studies used ELISA and dot blot 
assays directed to the EM antigen (the Denkey kit ; Globio Co. , Beverly , Mass) 
and the NS1 antigen demonstrated that high concenterations of the EM and 
NS1antigen demonstrated that high concenterations of the E/M  and NS1 
antigens in the form of an immune complex could be detected in the acute –
phase sera of both patients with primary dengue virus infections and patients 
Review of Literature 
 28 
with secondary dengue virus infections up to 9 days after the onset of illness. 
Koraka et al recently reported on the detection by a dot blot immunoassay of 
immune complex –dissociated NS1 antigen in patients with acute dengue virus 
infections. Although it is demonstrated the potential of NS1 antigen detection 
for the serodiagnosis of acute dengue virus infection , the relatively low rate of 
positive results by the RT-PCR assay reported in the study suggested that it was 
under estimated . In addition, many RT-PCR-positive samples showed negative 
results when they were analyzed by this NS1 antigen detection method. The 
serological diagnosis of dengue  virus infection is rather complicated for the 
following reasons : 1) patients may have multiple and sequential infections with 
four dengue virus serotype due to lack of cross-protective neutralisation 
antibodies, 2)multiple and sequential flavivirus infection make differential 
diagnosis difficult due to the presence of pre-existing antibodies and original 
antigenic regions were two or more flavivirus are co circulating 3) IgG 
antibodies have high degrees of cross- reactivity to homologous and 
heterologous flavivirus antigens ; and 4) the serodiagnosis of past , recent , or 
present dengue infections is difficult due to prolonged persistence of IgG 
immunoglobulin’s (>/= 10 months , as measured by E/M specific capture IgG 
ELISA , or lifelong , as measured by E/M antigen-coated indirect IgG ELISA ) 
in many dengue patients with secondary infections . Thus among the dengue 
viral infections that can be diagnosed by serological methods   is  the most 
challenging. Several methods have been described for the serological detection 
of  dengue virus – specific antibodies , including the haemagglutination 
inhibition (HI) test , the neutralisation test , the indirect immunofluorescent –
Review of Literature 
 29 
antibody test , ELISA, complement fixation , dot blotting , western blotting and 
the rapid immunochromatography test ( for which many commercial kits are 
available). Among these, capture IgM and /or IgG ELISA , antigen coated 
directed IgM and /or IgG ELISA and the HI  test are commonly used serological 
techniques for the routine diagnosis of dengue viral infections. Traditionally the 
HI test was used to differentiate between primary and secondary dengue 
infections due to its simplicity, sensitivity, and it was reproducible. Patients 
were classified as secondary dengue virus infections when the HI test titre in 
their sera is greater than or equal to 1:2,560 and were classified as having 
primary dengue virus infection if the HI test titre is less than 1:2,560. The HI 
test is now less popular and has gradually been replaced by the E/M-specific 
capture IgM and IgG ELISA. The E/M –specific capture IgM and IgG ELISA 
has become the most powerful assay for the serodiagnosis of dengue virus 
infection due to its high sensitivity, specificity , simplicity , and feasibility . 
Anti-dengue virus IgM immunoglobulins may be produced transiently during 
primary and secondary infections. In patients with primary dengue infections, 
IgM immunoglobulin’s develop fast and are detectable on days three to five of 
illness in half of the hospitalised patients .Studies have shown that anti-dengue 
virus IgM levels peak at  about 2 weeks post infection and then decline to 
undetectable levels over 2 to 3 months . Anti-dengue virus IgG appears shortly 
afterwards28. 
¾ In 2004, Sergio et al published a journal on the laboratory tests that the clinician 
must know to reach a correct diagnosis.  In Brazil, the increase in the incidence 
of dengue was especially linked to the dissemination of Aedes aegyptii . Thus a 
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rapid and accurate dengue diagnosis was of paramount importance for effective 
control of dengue outbreaks. Five serological test have been used for the 
diagnosis of dengue infection; haemagglutination inhibition (HI ), complement 
fixation (CF), Neutralisation test (NT ) , IgM ELISA and indirect IgG ELISA. 
The limitation of the above test are high degree of cross reactivity observed with 
these tests. Four methods of viral isolation had been routinely used for dengue 
viruses; intracerebral inoculation of newborn mice, inoculation on mammalian 
cell cell cultures, intrathoracic inoculation of adult mosquitoes, and inoculation 
on mosquito cell cultures . In recent years, several new diagnostic techniques 
have been developed and have proved very useful in dengue fever diagnosis , 
such as; nucleic acid hybridisation , RT-PCR . Currently, dengue diagnosis is 
based on serology, viral isolation and RNA detection69. 
¾ In 2004, Innis etal  classified primary and secondary dengue infections by 
determining the ratio of the units of dengue virus IgM antibodies to the units of 
dengue virus antibodies to the dengue virus IgG antibodies. They had shown 
that acute-phase sera of patients with primary dengue virus infections had higher 
IgM/IgG ratios, where as patients with secondary infections had lower IgM/IgG 
ratios .This method had made a great contribution to the analysis of the immune 
status of the patient with dengue. Studies have shown that most patients with 
primary dengue virus infection would not have detectable IgM or IgG antibodies 
at 4 months post-infection. This is in contrast to the high IgG titres which was 
detected in many of the patients with secondary dengue even 10 months after 
infection70. 
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¾ In 2004, Ahluwalia  studied about  the earlier principal vector of dengue virus in 
Asia, Aedes albopticus which  has been replaced by Aedes  aegypti. 
Interestingly, Aedes aegypti had been described as having a relatively low oral 
receptivity for dengue virus as to Aedes albopticus .However , it has been 
recently documented that oral receptivity of Aedes aegypti to DEN-2 virus was 
significantly more than Aedes albopticus . Aedes aegypti tends to be more 
susceptible to infection by DEN-2 virus of South-east Asian genotype as 
compared to American genotype. These observations obviously have important 
epidemiological implicationsepidemiological implications for Asian countries as  
the local vector  has increased propensity to transmit dengue infection , 
especially  DEN-2  ( relatively more virulent serotype )71  . 
¾ In 2005, Kao L and Teles FR proposed that the IgM immunoglobulin response 
varies considerably among persons due to different  host immune response 70. 
¾ In 2005, Ngyugen et al have shown that there was no considerable association 
between sex, nutritional status of the patient and the severity of Dengue 
haemorrhagic fever and dengue shock syndrome72.  
¾ In 2005, Severine et al had used four dengue viral antigens for the determination 
of dengue immune status by ELISA of IgG avidity. IgG ELISA were used to 
determine the dengue immune status of 105 pairs of serum samples from 
patients infected with dengue virus. This study had shown  that a simple avidity 
test, for which only one acute – phase serum sample is required , is potentially 
more useful than haemagglutination inhibition test for the discrimination of 
primary from secondary infection , whatever the type of dengue antigen is 
used73 . 
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¾ In 2006, Lin CF suggested that anti-NS1 immunoglobulin’s induce endothelial 
cells to undergo apoptosis and invitro experiment had demonstrated that these 
antibodies are responsible for increased permeability in endothelial cell 
monolayer74.It is worth emphasizing that although E/M-specific IgG antibodies 
are highly cross reactive among various  flaviviruses during a secondary 
response , the E/M and NS1 –specific anti-dengue virus IgM antibodies have 
limited cross-reactivities. Therefore, the crossreactivity of dengue-specific IgM 
antibodies found in a few dengue patients may actually indicate a recent 
infection with another flavivirus . Some investigators have studied dengue virus 
–specific IgA and IgE antibody responses. Talarmin et al reported on the use of 
an IgA and IgM specific capture ELISA for the diagnosis of dengue virus 
infection. The results showed that IgM appears more rapidly and lasts   longer 
than IgA .They concluded that the capture IgA ELISA is a simple method that 
can be performed together with the capture IgM ELISA and that can help in 
interpreting the serology of dengue fever56 .  
¾ In 2006 Balmaseda et al reported that the dengue specific IgM and IgA 
antibodies can be detected in serum and saliva of dengue infections. They 
concluded that that dengue virus –specific IgA in serum can be a potential 
diagnostic target53. 
¾ In 2006, Dussart P etal  , suggested that NS1 antigen is chemically a 
glycoprotein that is essential for the viability of dengue virus and it is produced 
in two forms ;membrane associated and secretary forms. He also observed that 
Enzyme linked immunoassays directed against NS1 antigen have demonstrated 
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its presence in high concenterations in the sera of dengue virus infected patients 
during the acute phase of the disease75. 
¾ In 2006 to 2007 , Maria G. Guzman did a multicountry evaluvation of the 
sensitivity and specificity of two commercially available NS1 ELISA assays for 
dengue diagnosis. This study suggested that the best performing NS1 assays had 
a moderate sensitivity ( 64 % ) and a high specificity of 100 % for the dengue 
diagnosis . The combination of NS1 and IgM detection in samples collected in 
the first few days of fever increased the overall dengue diagnostic sensitivity76. 
¾ Nunes etal in 2006 and Chem YK etal in 2007 suggested that detection of 
secreted NS1 protein represents a new approach to the diagnosis of acute dengue 
infection . A recently developed commercially available diagnostic test based on 
dengue NS1 antigen capture ELISA was investigated in two studies (one in 
South America and the other in South-east Asia).  The test had an overall 
sensitivity of 88.7 % and 93.4 % in the two studies, with 100% specificity77,78. 
¾ In 2006, Ravulapalli  et al studied recombinant multiepitope protein for early 
detection of dengue infections . A customised recombinant  dengue multiepitope 
protein (r-DME-G) that can specifically detect the immunoglobulin G (IgG) 
class of anti- dengue antibodies in patient sera was developed. Using this 
strategy, another dengue multiepitope protein, r-DME –M with specificity for 
IgM class of anti-dengue antibodies. A synthetic gene encoding the r-DME-M 
was expressed as a maltose –binding fusion in Escherichia coli. The 
recombinant protein was purified in a single affinity chromatographic step to 
obtain yields of 15 mg purified protein/litre of culture. The purified protein was 
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used to develop an in-house IgM ELISA and tested using a panel of 172 patient 
sera characterised using the commercially available Dengue Duo rapid strip test 
from Panbio , Australia .  The IgM ELISA results showed that the r-DME-M 
protein not only recognised all IgM samples identified by the Panbio test but 
also identified samples missed by the latter test37. 
¾ In 2006, Herman et al had studied the extent to which immune responses 
contribute to the long term protective immunity afforded by natural primary 
DENV infection has not been fully defined . Neutralisation of infection in 
monocytic cells (instead of enhancement of infection) may be more strongly 
associated with protection from DHF, although this association has been 
reported in only one study. Humans can experience three sequential 
heterologous dengue infections. Importantly, the occurrence of a second and 
third infection in individuals with pre-illness antibodies against multiple dengue 
serotypes indicates that neutralizing antibodies are cross- reactive invitro but not 
cross-protective in vivo79. 
¾ In 2006, M Moorthy has conducted a study to evaluate the sensitivity of rapid 
immunochromatographic test (ICT ) device in detecting antibodies to dengue 
virus in tertiary hospital in South India . Sera from hospital attendees, with 
requests for dengue virus antibody testing were tested with Dengue duo cassette 
and a reference antibody capture assay for detection of IgM and IgG antibodies. 
The ICT results were compared with results of antibody capture tests for 
detection of IgM and IgG antibodies respectively. Accuracy indices for IgM and 
IgG detection respectively were; sensitivity 81.8% and 87.5%, specificity 75 % 
and 66.6% , positive predictive value (PPV) 61% and 72.9% and negative 
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predictive value 89.6% and 83.9% . The device performs poorly in detection of 
IgM and IgG antibodies to dengue viral infections and is not recommended for 
use as a standard –alone diagnostic procedure80. 
¾ In 2007,  Uma Reddy et al reported that dengue viral  infection specifies the 
activation of unfolded protein response .  Recently, virus induced apoptosis 
mediated by the unfolded protein response ( UPR ) has been hypothesised to 
represent a crucial pathogenic event in viral infection . In an attempt to evaluate 
the contribution of the UPR to virus replication , They  have characterized each 
component of this signalling pathway following dengue virus infection .  This 
study proved that dengue virus infection, A549 cells elicits an UPR which is 
observed at the level of translation attenuation and activation of specific of 
specific pathways such as nuclear translocation of ATP-6 and splicing of XBP-
1. Interestingly, the study found that specific serotype of virus modulate the 
UPR with different selectivity. In addition we demonstrate that perturbation of 
the UPR by preventing the dephosphorylation of the translation initiation factor 
elf2alpha using Salubrinal considerably alters virus infectivity. This report 
provides evidence that dengue infection induces and regulates the three branches 
of the UPR signalling cascades. This is a basis for our understanding of the viral 
regulation and conditions beneficial to the virus infection . Furthermore , 
modulators of UPR such as Salubrinal that inhibit dengue replication can open 
up an avenue toward cell- protective agents that target the endoplasmic 
reticulum for anti-viral therapy70 . 
¾ In 2007, Puttikhunt etal demonstrated that secreted NS1 antigen attaches to the 
surface of the cells via interactions with heparin sulphate and chondroitin 
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sulphate. This study also demonstrated that soluble NS1 protein binds to 
endothelial cells and following recoginition by anti-NS1 antibodies, could 
contribute to plasma leakage during severe dengue viral infection81. 
¾ In 2007, Kurosu et al suggested that patients with an elevated level of free 
soluble form of dengue virus (DV) non structural protein 1 (sNS1 ) are at risk of 
developing dengue  haemorrhagic fever. Complement inhibitory factor Clusterin 
(Clu), which naturally inhibits the formation of terminal complement complex 
(TCC ) was identified by mass spectrophotometry . Since an activated 
complement system reportedly cause vascular leakage, the interaction between  
NS1 and Clu may contribute to the progression of dengue haemorrhagic fever 82. 
¾ In 2007 Koraka et al reported that the capture IgE ELISA can detect total and 
dengue virus-specific IgE antibody responses .  The results showed that dengue 
virus specific IgE titres were significantly higher in patients with dengue fever 
and non-dengue virus infections. They concluded that analysis of dengue virus 
specific IgE ELISA might contribute to the understanding to the understanding 
of the pathogenesis of dengue virus 83. 
¾ In 2007, Sierra studied Cuban DHF/DSS outbreaks .This study had provided 
evidence of a reduced risk of people of Negroid race for DHF/DSS compared to 
those of Caucasoid race. Taking into consideration the origins of contemporary 
Cuban inhabitants, the Cuban, Carribean Black and African populations share a 
common gene pool that could explain, at least partially, the low incidence of 
dengue haemorrhagic in Cuba and Caribbean and African countries. The central 
role played by immunological mechanisms in the pathogenesis  of  DHF/DSS  
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has led to consider that the polymorphic genes associated with immune response 
must be carefully considered among those human genes regulating regulating 
dengue disease severity that might be distributed unequally in Blacks and 
Whites84 .  
¾ In 2007, Avirutnam P etal said that NS1 levels can enhance  complement 
activity in solution and or by directly binding endothelial cells and may establish 
foci for immune complex formation leading  to complement activation , 
endothelial damage and capillary leakage81.The virus which is found in the 
serum or plasma  , for 2-7 days , corresponding to the days of fever . Person 
never previously infected with a flavivirus nor immunised with a flavivirus 
vaccine , mount a primary antibody response when infected with the virus .The 
dominant immunoglobulin isotype is IgM . The haemagglutination inhibiting 
antibody appears simultaneously with IgM antibody. IgG appears shortly 
afterwards. Individuals with immunity immunity due to previous flavivirus 
infection or immunisation mount a secondary ( anamnestic) antibody when 
infected with dengue virus. Here the dominant immunoglobulin type is IgG. 
IgM appears in most instances, but its levels are lower than that observed in 
primary infections70. 
¾ In 2007, Sekaran had suggested that the NS1 antigen detection rate decreases as 
level of IgM antibody  increases 85. 
¾ In 2007, a special issue on Dengue news letter  described about feeding habit 
about the vector  Aedes aegypti  which is a day biter with increased biting 
activity 2 hours after sunrise and several hours before sunset, feeds in domestic 
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and peridomestc situations . It bites repeatedly. They rests in the domestic and 
peridomestic situations in the dark corners of the houses , on hanging objects 
like clothes , umbrella or under the furniture . Aedes aegypti mosquito breeds in 
any type of man made containers or storage containers having even a small 
quantity of water .Eggs of Aedes aegypti can live without water for more than 
one year. Desert coolers, drums, jars, pots, buckets, flower vases, lant saucers, 
tanks, cisterns, bottles, tins, tyres, roof gutters, refrigerator drip, pans, cement 
blocks, cementary urns, bamboo stumps, coconut shells, tree holes and many 
more places where rainwater collects or is stored32 . 
¾ In 2008, Bess of K suggested that NS1 antigen circulates  uniformly in all types 
of dengue viral infections and it circulates at high levels during the first few 
days of illness 86. 
¾ In 2008, Arthur reported that the live attenuated vaccines had been developed  
for dengue which could provide an economically viable approach to inducing 
durable  humoral and cellular immunity. Neutralising antibodies are known to 
mediate protection from re-infection with a homologous serotype, and long term 
immunity to dengue viruses has been described. The virus must be able to 
replicate sufficiently well in vivo to provoke an immune response, but must be 
sufficiently restricted in systemic replication to avoid inducing any of the 
dengue-associated symptoms. The vaccines need to induce a broad neutralising 
antibody response against each serotype, thus avoiding preferential antibody 
reponses to the better replicating components, leading to disease susceptibility. 
For over twenty years, monovalent live attenuated vaccine candidates leading to 
disease susceptibility. For over twenty years monovalent live attenuated vaccine 
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candidates, propagated and attenuated in primary and diploid cell cultures had 
been evaluvated in human beings87.  
¾ Halstead and Marchette made the first successful monovalent vaccine using 
primary dog kidney cells. Several monovalent vaccines passaged through 
primary dog kidney cells were developed and combined into several tetravalent 
formulations that have been tested in phase 1 and 2 trials in American adult 
volunteers or Thai adults and children where they were shown to be safe and 
immunogenic22 . 
¾ In 2008 , Lertwongrath S etal proved that if NS1 antigen detection in acute 
phase sera is combined with dengue viral IgM detection in early convalescent 
phase sera  , a sensitivity of about 90% in dengue diagnosis could be obtained88. 
¾ In 2008, Shrivastava etal established that  NS1 antigen ELISA can be used in 
early diagnosis of dengue viral  infections. Out of 91 clinical samples 26 % were 
positive by NS1 antigen capture ELISA, 16% positive by SD Dengue NS1 
antigen test and 12% positive by RT-PCR analysis15. 
¾ In 2008, Kumarasamy V etal said that dengue early ELISA has the added 
advantage of giving a good detection rates up to 7 days of illness89. 
¾  2008,  Jose reported the ophthalmic complications in dengue infections are rare. 
The main ocular findings include subconjunctival haemorrhages, macular 
oedema and blot haemorrhages. Less common features include exudative retinal 
detachment, cotton wool spots, glaucoma and anterior uvietis. A majority of 
patients were reported to have residual visual impairment90. 
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¾ In 2008, Chien had described about the iatrogenic complications include water 
intoxication, sepsis due to contaminated iv lines, pneumonia, wound infections, 
heart or respiratory failure due to over hydration. Simultaneous infections such 
as leptospirosis, viral hepatitis, typhoid fever, chicken pox, meliodosis had been 
reported and could contribute to unusual manifestation91.  
¾ In 2008, Webster reported that subunit vaccine have poor immunogenicity and 
need potent immunostimulatory adjuvants that activate the innate immune 
system and there by elicit antigen-specific immune responses.  Monophosphoryl 
lipid A is a detoxified form of the endotoxin lipopolysaccharide, and is among 
the first of a new generation of toll –like receptor agonists likely to be used as 
vaccine adjuvants on a mass scale in human populations. A recombinant subunit 
protein containing the amino-( N )terminal 80% of the DENV2 envelope protein 
had been studied in formulations with one of the five different adjuvants based 
on aluminium, fractions QS-21 of saponin , and monophosphoryl lipid A. In 
mice, all formulations were immunogenic with evidence of non-sterilising 
protective efficacy. A new tetravalent protein vaccine candidate has been 
developed that comprises a consensus dengue virus envelope dengue virus 
protein domain III (cEDIII) obtained by alignment of aminoacid sequences from 
different isolates of all four serotypes. Formulation of recombinant Ced111 with 
aluminium phosphate induces cross-reacting antibodies and memory immunity 
after challenge with dengue virus in mice. DNA vaccines use plasmids of 
double-stranded DNA in which the genetic sequence for a protein or series of 
epitopes has been inserted under the control of a mammalian promoter. They are 
usually given intramuscularly and are taken up by muscle and dendritic cells, 
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where the genetic information for the encoded protein is translated . Several 
dengue DNA vaccines have been developed. Although DNA vaccines showed 
early promise in other disease models in animals, DNA vaccination generally 
elicits only weak immune responses in people although they are effective at 
priming cellular immune responses, including those of T-helper -1 type CD4 T 
cells and CD8 cytotoxic T cells, for boosting by recombinant viruses70.    
¾ In 2008, S Datta has undertaken a study to evaluvate the efficacy of NS1 antigen 
assay as an early marker for dengue virus infection Group I evaluvated the 
performance of NS1 antigen assay in comparison to MAC- ELISA and their 
detection rate when performed together in a single sample. Six hundred acute / 
early convalescent sera were screened by both assays. Group II evaluvated the 
efficacy of a single assay in 30 acute phase sera of pediatric OPD patients 
screened only by NS1 antigen assays. Group III evaluvated the specificity of 
NS1 assay in comparison to MAC- ELISA on 40 samples included as controls. 
In Group 1 23% and 39% were positive by NS1 antigen assay and MAC – 
ELISA respectively .The detection rate increased to 53 % when both the assays 
were used together on a single sample. NS1 antigen positivity varied from 71 % 
to 28 % in acute and early convalescent sera, conversely IgM detection rate was 
93% and 6% in early convalescent and acute phase sera respectively. In Group 
11 66 % samples were positive by NS1 assays. The above study shows that NS1 
antigen assays holds promise in early dengue infection 8. 
¾ In 2008 Dussart etal did a study which compared the performance of two new 
commercial test kits for detection of NS1 antigen during the clinical phase of 
dengue virus infection - an immunochromatographic test allowing rapid 
Review of Literature 
 42 
detection of NS1 antigen , Dengue NS1 antigen strip  , and a two step sandwich 
format  microplate ELISA , the Platelia Dengue NS1 Ag test.272 serum samples 
from patients with dengue disease were tested . Of these 222 were from patients 
with acute infection with one of the four serotypes of dengue virus, detected by 
RT PCR and or virus isolation .Fourty-eight acute phase serum  samples from 
patients not infected dengue virus were also included.The sensitivity of Platelia 
Dengue NS1 Ag test on acute serum samples was 87.4 %; that of Dengue NS1 
Ag strip was 81.5 % after 30 minutes. Both tests had specificity 100%. The Pan 
–E Dengue Early ELISA had a sensitivity of 60.4 % and a specificity of 97.9%. 
These findings support the use of NS1 antigen detection for the diagnosis of 
acute dengue viral infection. The immunochromatographic was highly sensitive 
and specific, and would therefore be a suitable first line test in the field. 
¾ In 2008, Datta  evaluvated the  NS1 antigen assay for early diagnosis  of  dengue 
viral infection . Group I evaluvated the performance of NS1 antigen assay in 
comparison to MAC-ELISA and their detection rate when performed on a single 
sample .Six hundred acute/early convalescent sera were screened by both 
assays. Group11 evaluvated the efficacy of a single assay in 30 acute phase sera 
of pediatric OPD patients screened only by NS1 antigen assay. Group III 
evaluated the specificity of NS1 assay in comparison to MAC-ELISA on 40 
samples included as controls. In Group 1, 140 (23%) and 235 (39%) samples 
were positive by NS1 assay and MAC-ELISA respectively. The detection rate 
increased to 53 % when both assays were used together. From this study it was 
concluded that NS1 antigen assays holds promise in early diagnosis of dengue 
viral infections9. 
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¾ In 2008, Vu Hang etal suggested that NS1 assays can be included in the 
diagnostic evaluvation of dengue patients, but with due consideration for the 
limitations in patients, who present late in their illness or have a concomitant 
humoral immune response. The sensitivity and specificity of NS1 ELISA and a 
NS1 lateral flow rapid test were compared against a gold standard reference 
diagnostic algorithm 138 Vietnamese children and adults. Overall, NS1 ELISA 
was modestly more sensitive (82%) than NS1 LFRT  (72%) in confirmed 
dengue cases92. 
¾ In 2009, Subhash C Arya reported NS1 detection in addition to reverse 
transcriptase PCR and Transcription mediated amplification of dengue virus in 
acutely ill patients .The study have attempted to determine the utility of RT-
PCR in relation to  the appearance of the DENV NS1 antigen . NS1 antigen 
detection appeared to be better than RT-PCR for eg, ports in Taiwan was 
instrumental in the detection of 19RT-PCR-negative travellers who would have 
been labelled DENV negative . Two of them turned out to be IgM positive on 
the day 17 or day 18 of illness93.  
¾ In 2009 , Vazquez etal  reported the application of monoclonal antibody to 
dengue capsid protein in dengue studies22 .   
¾ In 2010, Aryati et al did a study on the performance of  dengue NS1 antigen 
ELISA and molecular analysis of NS1 gene of dengue viruses obtained during 
surveillance in Indonesia. The NS1 and IgM/IgG ELISA assays were used for 
screening and confirmation of dengue infection during the surveillance in 2010-
2012. Collected serum samples (n=440) were subjected to RT-PCR  with virus 
isolation in which 188 samples were confirmed for dengue infection. The 
Review of Literature 
 44 
positivity of the ELISA assays were correlated with the RT-PCR results to 
obtain the sensitivity of the assays. The NS1 genes of 48 Indonesian birus 
isolates were sequenced and their genetic characterstics were studied. Using 
molecular data as the gold standard , the sensitivity of NS1 ELISA assay for 
samples from Indonesia was 56.4 % while IgM ELISA   was 73.7% .When both 
NS1 and IgM results were combined , the sensitivity increased to 89.4 % . The 
NS1 sensitivity varied when correlated with city /geographical origins and 
DENV serotype, in which the lowest sensitivity was observed for DENV-4 . 
NS1 sensitivity was higher in primary compared to secondary infection . The 
specificity of NS1 assays for the non-dengue samples were 100%. The NS1 
gene sequence analysis of 48 isolates revealed the presence of polymorphism of 
the NS1 genes which  did not influence the NS1 sensitivity94. 
¾ In 2010, Subhash C Arya, conducted a study when there was increase in dengue  
viral infections in New Delhi. This study was conducted at Sant Parmanand 
Hospital during this outbreak to determine the utility of Dengue package, 
comprising simultaneous detection of dengue NS1 protein , anti-dengue IgM 
antibodies, anti-dengue IgG antibodies and platelet enumeration. Blood samples 
were tested for dengue NS1 antigen, IgM and IgG antibodes using single step 
immunochromatographic test. Of the 1886 patients screened with dengue 
package, 678 were NS1 positive . The platelet count was lower in NS1 positive 
than in NS1 negative cases 93. 
¾ In 2010, Thomas etal has suggested that the dengue viral NS1 antigen (that 
develops right at the beginning of feverish period and before appearance of 
dengue  antibodies ), is emerging as a suitable option for dengue diagnosis22. 
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¾ In 2010 Seok etal had evaluvated  a commercial dengue virus NS1 Antigen 
Capture Enzyme Linked Immunosorbent Assay kit for early diagnosis of dengue 
viral infection. A total of 399 serum samples in comparison with real time PCR , 
an in-house IgM capture ELISA ( MAC-ELISA ) and an haemagglutination 
inhibition assay.  Of the 320 dengue sera , 64% tested positive for NS1 antigen 
compared to 93% by either MAC-ELISA or RT-PCR , 50% by RT-PCR and 
70% by MAC-ELISA only. The NS1 detection rate was inversely proportional 
while the IgM detection rate is directly proportional to the presence of IgG 
antibodies. The overall sensitivity and specificity of NS1 antigen ELISA in the 
detection of confirmed dengue virus sera are 76.76 % and 98.31 % respectively. 
This suggests that NS1 antigen ELISA has a high degree of sensitivity and 
specificity  for detection of dengue viral infection95. 
¾ In 2010, Guzman et al has hypothesised that the sensitivity of NS1antigen test 
can differ according to dengue virus serotype and a reduced sensitivity of NS1 
assays for DENV-2 serotype37 . 
¾ In 2010, Alvina etal found  a lower sensitivity of  protein tests during a dengue  
type 2 virus outbreak in Santos , Brazil. The detection of NS1 antigen was used 
for diagnosis in addition to the detection of IgG , IgM  and RNA , A large 
number of NS1 false negative results were obtained , A total of 379 RNA 
positive samples were selected for thorough evaluvation . NS1 was reactive in 
37 % of cases .Most of the cases were characterised as a secondary dengue 
infection by dengue virus 2 18. 
¾ In 2010, Alvina et al observed low sensitivity of NS1 protien tests evidenced 
during a dengue type 2 virus outbreak in Santos, Brazil, in 2010. 
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¾ In 2010, Shamala etal  used commercial Dengue Duo rapid test kit for early 
diagnosis by detection of dengue virus NS1 antigen and immunoglobulin IgM 
/IgG antibodies . A total of 420 serum samples were subjected to real time PCR, 
in-house IgM capture  ELISA, haemagglutination inhibition assay and the SD 
Dengue Duo rapid test. Of the 320 dengue acute and convalescent sera, dengue 
infection was detected by either serology or by RT-PCR in 300 samples as 
compared with 289 samples in the combined SD Duo NS1 /IgM . The NS1 
detection rate is inversely proportional whereas IgM detection rate is directly 
proportional to the presence IgG antibodies. By this study it was shown that 
detection of both NS1 and IgM by SD duo gave comparable detection rate by 
either serology or by RT-PCR95. 
¾ In 2010 , Vianney et al compared the sensitivity, specificity and relationship to 
viraemia of two dengue NS1 rapid tests. The NS1 rapid tests had similar 
diagnostic sensitivities in confirmed dengue cases but were 100 %  specific . 
When IgM/IgG results from the SD Dengue Duo were included in the test 
interpretation , the sensitivity improved significantly from 62.4 % with NS1 
alone to 75.5 % when NS1 and/or  IgM  was positive and 83.7% when NS1 and 
/or IgM and /or IgG was positive . Both NS1 assays were significantly more 
sensitive for primary than secondary dengue. NS1 positivity was associated with 
the underlying viraemia as NS1 –positive samples had a significantly higher 
viraemia than NS1 – negative samples96. 
¾ In 2011, Pallavi etal  reported on the rational use of platelet transfusion in 
dengue fever. The practise of platelet transfusion has been adapted into standard 
clinical practise in management of hospitalised dengue patients. The exact 
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indications and situations in which platelet have to be transfused may vary 
greatly. Blood components especially platelet concenterates due to their short 
shelf life are frequently in limited supply. Hence appropriate use of blood is 
required to ensure the availability of blood for patients in whom it is really 
indicated, as well as to avoid unnecessary exposure of the patients to the risk of 
transfusion reaction and blood borne infection. Clinical data from 343 
serologically confirmed dengue patients admitted at JSS University between 
1stJanuary and 30thAugust were collected. The prevalence of thrombocytopenia 
was 64.72 % and bleeding manifestation were recorded in 6.12% patients97.  
¾ In2011, Jayashree said that platelet can be used as a parameter to evaluvate the 
outcome of dengue fever. The major pathophysiological hallmark which 
determine disease severity and differentiate Dengue haemorrhagic fever from 
Dengue fever and other viral haemorrhagic fever is plasma leakage due to 
increased vascular permeability and abnormal homeostasis . Hypovolemic shock 
occurs as a consequence of and subsequent to, critical plasma volume loss 
.Abnormal hemostasis including increased  capillary fragility, thrombocytopenia 
, impaired platelet function, consumptive coagulopathy and in the most severe 
form disseminated intravascular coagulation contribute to haemorrhagic 
manifestation 98. 
¾ In 2011, Dongmei et al reported the kinetics of non-structural protein 1, IgM and 
IgG antibodies in dengue type 1 primary infection. A panel of 313 acute and 
early convalescent phase sera specimens from 140 DENV1 primary infected 
patients during an outbreak of dengue in Guangzhou, China, in 2006 were 
studied. Dengue NS1 presented high levels in acute-phase serum samples. It was 
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detectable as early as 1 day of illness and up to 14 days after onset. The 
sensitivity of NS1 detection was ranged from 81.8% to 91.1% with samples 
taken during the first 7 days. Anti-dengue IgM antibody was detectable on the 
third day of onset with the positive rate 42.9%, and rapidly increasing to 100% 
by day 8 of illness. Anti-dengue IgG antibody was detectable on the fifth day of 
onset with low level at the first week of onset, and slowly increasing to 100% by 
day 15 of illness. Combining the results of NS1 and IgM antibody detection 
allowed positive diagnosis in 96.9% -100% for samples taken after 3 days of 
onset .Dengue NS1 detection might shorten the window period by the first few 
days of illness . A combination of Dengue NS1 antigen and IgM antibody 
testing facilitates enhanced diagnostic rates. The procedures should be suitable 
for developing countries where dengue is endemic 99. 
¾ In 2011 Zandi et al reported that four different types of bioflavanoid has 
antiviral activity against dengue virus type 2. Dengue is a major mosquito –
borne disease currently with no effective antiviral or vaccine available. Effort to 
find antivirals for it has focussed on bioflavanoids, a plant derived polyphenolic 
compounds with many potential health benefits. In this study antiviral activity 
shown by four types of bioflavanoid against dengue virus -2 in vero cell is 
evaluvated. Anti-dengue activity of these bioflavanoid compounds were 
determined at various stages of DEN-2 infection and replication cycle. DENV 
replication was measured using   Foci Forming Unit Reduction Assay (FFURA) 
and quantitative RT-PCR . Selectivity Index Value (SI) were determined as the 
ratio of cytotoxic concenteration 50 (IC50) for each compound. The half 
maximal inhibitory concenteration of quercetin against dengue virus was 35.7 
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microgram/ml when it is used after virus adsorption into the cells . The IC50 
decreased to 28.9 microgram/ml when the cells were treated continuously for 5 
hour before virus infection and up to 4 days post-infection. The SI values for 
quercetin were 7.07 and 8.74 microgram/ml respectively, the highest compared 
to all bioflavanoids studied. Naringin only exhibited anti adsorption effects 
against DENV2 with IC50 =168.2 microgram /ml and its related SI was 1.3. 
Daidzein showed a weak anti-dengue activity with IC50= 142.6 microgram/ml 
when the DENV 2 infected cells were treated after virus adsorption . The SI 
value for this compound was 1.03. Hesperetin did not show any antiviral activity 
against DENV2. The findings obtained from FFURA was corroborated by 
findings of the RT-PCR assays. Results from this study suggested that only 
quercetin had shown significant anti-DENV -2 inhibitory activities. Other 
bioflavanoids had demonstrated minimal  to no significant inhibition of DENV-
2 virus replication. These findings, together with those previously reported 
suggest that select group of  bioflavonoids including quercetin and fisetin , 
exhibited significant inhibitory activities against dengue virus . This group of 
flavanoids , flavonol , may be investigated further to discover the common  
mechanisms of inhibition of dengue virus replication100.  
¾ In 2011, Blacksell etal diagnosed acute dengue infections using six commercial 
point-of care tests from 259 Sri Lankan patients with acute fevers  (99 
confirmed dengue cases and 160 patients with other confirmed acute febrile 
illness); 1) the Merlin dengue fever IgG and IgM combo device , 2) Standard 
diagnostics Dengue Duo non structural (NS1) antigen   and IgG and IgM combo 
device  , 3 )the Biosynex  dengue fever IgG and IgM assays  ,4) Bio-rad NS1 
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antigen strip 5)Panbio  Dengue Duo IgG /IgM cassette  6) Panbio dengueNS1 
antigen strip.  The median number of days of fever prior to admission sample 
collection was 5 days . Sensitivity and specificity of the NS1 antigen tests 
ranged from 49 to 50 % and from 93% to 99% respectively, and  the sensitivity 
and specificity of the IgM antibody ranged from 71 to 80% and from 46 to 90% 
respectively. Combining NS1 antigen and IgM antibody results from the 
Standard Diagnostics Dengue Duo test gave the best compromise of sensitivity 
and specificity (93 and 89% respectively) and provided the best sensitivity in 
patients presenting at different times after the fever onset. The Merlin IgM/IgG 
antibody tests correctly classified 64% and 86% of the primary and secondary 
dengue infection cases respectively, and the Standard Diagnostics IgM /IgG 
antibody tests correctly classified 71% and 83% of the primary and secondary 
dengue infection cases, respectively . This study provides strong evidence of the 
value of combining dengue antigen –and –antibody –based test results in the 
rapid diagnostics test (RDT ) format for the acute diagnosis dengue101 . 
¾ In 2011 , Anne etal did a retrospective study  which showed that the sensitivity  
of the combined kit did not vary significantly between the serotypes and was not 
affected by the immune status or by the interval of time between onset of fever 
and sample collection. The aim of the study was to evaluate a combined dengue 
rapid test for detection of NS1 antigen and IgM/IgG antibodies . During the 
prospective study , 157 patients were hospitalised for suspicion of dengue fever  
were enrolled . In  the hospital laboratory, the overall sensitivity , specificity , 
positive predictive value (PPV ) and negative predictive valueof NS1 /IgM, IgG 
combination test was 87.5%, 83.9%, 95.6% and 59.1% respectively , whereas 
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they were 94.4% , 90% , 97.5% , 77.1% respectively in National Reference 
Laboratory at Institute Pasteur , Cambodia102. 
¾ In 2011 Kulkarni etal had done study showing the association between platelet 
count and NS1 antigen. Serum samples from clinically suspected dengue cases 
were tested for NS1 , IgM, IgG by immuochromatography –based test. Platelet 
counts were obtained for all the positive cases and 150 dengue seronegative 
cases of fever that served as controls. Test results of dengue specific parameters 
were compared against platelet counts. Of the 2104 samples tested, 320 were 
positive for one or more dengue parameters . Of the 320 , 95 were positive for 
NS1 only , 161 showed  IgM only while 9 showed IgG only . More than one 
marker was detected in the remaining 55 samples . Thrombocytopenia was more 
consistently associated whenever NS1 was detected compared to antibody 
detection 1. 
¾ In 2012 , Ruthven teal had evaluated the platelet count in dengue fever along 
with seasonal variation with seasonal variation of dengue infection .Blood 
samples were collected from 1549 patients experiencing a febrile illness, 
clinically consistent with dengue infections . Serological confirmation of dengue 
infection was done and platelet count was done in all serologically positive 
cases.294 cases were confirmed as serologically positive. The difference 
between serologically positive cases during different months was significant. 
Larger proportions of serologically positive cases were observed among adults. 
Outbreak co-incised mainly with the post monsoon period and was significantly 
higher103.   
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¾ In 2012, Pan Teal reported that Granulate –binding protein 1 participates in 
cellular antiviral response to dengue virus   . Quantitative RT-PCR  and Western 
blot showed that   the expression  of   mouse Gbp1   was regulated in DENV-
infected  RAW264.7 cells . The intracellular DENV loads were significantly 
higher in Gbp1 silenced cells compared with controls . The expression levels of 
selective anti-viral cytokines were decreased in Gbp1 RNA treated cells, while 
the transcription factor activity of NF-KB was impaired upon Gbp1 silencing 
during infection104. 
¾ In 2012, Hughes et al reported the manipulation dengue virus E protein epitomes 
reduces potential antibody –dependent enhancement. Reducing the cross 
reactivity in the envelope glycoprotein of DENV may be an approach to 
improve the quality of the anti-DENV immune response. Sera from mice 
immunised with wild type, fusion peptide -,or domain III – substitution 
containing vaccines enhanced heterologous DENV infection invitro , unlike sera 
from mice immunized with a vaccine containing a combination of fusion peptide 
and domain III substitution. Passive transfer of immune of immune sera from 
mice immunised with fusion peptide and domain III substitutions also reduced 
the development of severe DENV disease in AG129 mice when compared to 
mice receiving wild type immune sera105.  
¾ In 2012, Jayratne et al evaluvated the WHO revised criteria for classification of 
clinical disease severity in acute adult dengue infection. The WHO guidelines 
were revised recently to identify patients with severe dengue (SD) early. The 
study was proceeded to determine the usefulness of the warning signs in the new 
WHO –guidelines in predicting the SD and we have also attempted to define 
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other simple laboratory parameters that could be useful in predicting the SD. 
Clinical and laboratory parameters were recorded in 184 patients in 2011, with 
confirmed dengue viral infections, admitted to a medical ward in two tertiary 
care hospitals in Colombo, Sri Lanka. The presence of 5 or more dengue 
warning signals were significantly associated with the development of severe 
dengue. The AST levels were significantly higher in patients with abdominal 
pain associated with severe dengue. High AST levels were also significantly 
associated with severe dengue. Platelet counts <20,000    cells /mm3 were again 
significantly associated with severe disease .The PCR was positive in 26/84 of 
the patients and the infecting serotype was found to be DEN1 in all 26 
patients106.  
¾ In 2012, Alfonso etal reported phylogenetic relationship between  dengue virus 
type 3 isolated in Brazil and Paraguay and global evolutionary divergence 
dynamics.  Dengue is the most important mosquito –borne viral disease world 
wide. Dengue virus comprises four antigenically related viruses named dengue 
virus type 1 to 4. DEN-3 was re-introduced into the Americas in 1994 causing 
outbreaks in Nicaragua and Panama. DEN-3 was introduced in Brazil in 2000 
and then spread to most of the Brazilian States , reaching the neighbouring 
country , Paraguay in 2002 . In this study , we have analysed the phylogenetic 
relationship of DEN-3 isolated in Brazil and Paraguay with viruses isolated 
worldwide . We have also analysed the evolutionary divergence dynamics of 
DENV3 viruses. The entire open reading frame (ORF) of thirteen DENV-3 
isolated in Brazil (n= 9)  within each genotype and Paraguay ( n=4) were 
sequenced for phylogenetic analysis .DENV – 3  grouped into three main 
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genotypes (I,II,and III) .Several internal clades  were  found within each 
genotype that we called lineage and sub-lineage . Viruses included in this study 
belong to genotypeIII and grouped together with viruses isolated in the 
Americas within the lineage III. The Brazilian viruses were further segregated 
into two different sub-lineage, A and B, and the Paraguayan into the sub lineage 
B. All three genotypes showed internal grouping. The nucleotide divergence 
was in average 6.7% for genotypes, 2.7% for lineages and 1.5 % for sub 
lineages. Phylogenetic trees constructed with any of the protein gene sequence 
showed the same segregation of the DENV-3 in three genotypes. This study had 
shown that two groups of DEN-3 genotype III circulated in Brazil during 2002-
2009, suggesting different events of introduction of the virus through different 
regions of the country . In Paraguay, only one group DENV3 genotype III was 
circulating that is very closely related to the Brazilian viruses of sublineage B   
Different degree of grouping can be observed for DENV3 and each group 
showed a characteristic evolutionary divergence. Finally, they observed  that 
any protein gene sequence can be used to identify the virus genotype . In 2012 
Jiang et al reported that the co-circulation of two genotypes of dengue virus 
serotype 3 seen in Guangzhou, China in 2009. Dengue is emerging as the most 
important mosquito borne viral disease in the world. In mainland China, 
sporadic  and large outbreaks of dengue illness caused by the four serotypes of 
dengue virus have been well documented . Guangdong province is the major 
affected area in China, and DENV1 has dominantly circulated in this area for a 
long time. In this study, a family cluster of DENV3 infection in Guangzhou was 
described. Three cases were diagnosed as dengue fever based on clinical 
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manifestation, serological and RT-PCR assays . Two DENV3 strains were 
isolated in C6/36 and the complete genome sequences were determined. 
Phyogenetic analysis revealed that the new DENV-3 isolates from the family 
cluster were grouped within genotype III. Considering the fact that several 
DENV-3 strains within genotype V is also identified in Guangzhou in 2009, at 
least two genotypes of DENV-3 also co-circulated.  Careful investigation and 
virological analysis is to be done in the future22. 
¾ In 2012, Satya etal did a study on atypical manifestations of dengue fever . A 
prospective hospital based observational study was conducted at hospitals of 
Kasturba  Medical College  in Manglore over a period of two years . 150   
ELISA confirmed IgM –dengue sero-positive cases satisfying WHO criteria 
were examined clinically and laboratory data assessed till they got discharged 
from hospital after ruling out other  causes of fever . Atypical manifestations in 
dengue fever were noted and analyzed . Most common symptoms noticed were 
myalgia , headache , rash , arthralgia , pain in the abdomen  and nausea . More 
than half of the study group had one or the other atypical manifestation . Liver 
function test derangement was most often seen . Most common atypical 
manifestation was hepatitis found in 40% patients . Febrile diarrhoea, renal 
failure ,acalculous cholecystitis and conduction abnormalities of heart were 
among other common manifestations . Three patients died of multi-organ 
dysfunction, disseminated intravascular coagulation and shock . Platelet count 
did not correlate with the severity of bleeding. Overall recovery rate was good. 
Clinical vigilance for these manifestations is important for timely detection and 
management as some of them could be fatal 107. 
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¾ In 2013, Stuart D Blacksell said that dengue fever, dengue haemorrhagic fever 
and, dengue shock syndrome  are tropical diseases that cause significant 
humanitarian and economic hardship . It is estimated    that more than 2.5 billion 
people are at risk of infection and more than 100 countries have endemic dengue 
virus transmission. Laboratory tests are essential to provide an accurate 
diagnosis of dengue virus infection so that appropriate treatment and patient 
management may be administered 108. In many dengue endemic settings, 
laboratory diagnostic resources are limited and simple rapid diagnostic tests  
(RDTs ) provide opportunities for point-of-care diagnosis.  
¾ In 2013,  Saurabh et al  studied the importance of platelet count and serological 
markers in diagnosing dengue infections with special reference to NS1 antigen . 
Serum samples from clinically suspected dengue cases were tested for NS1, IgM 
and IgG by immunochromatography based test . Platelet counts were obtained 
for  all positive cases and dengue seronegative cases of fever served  as controls 
. Test results of dengue – specific parameters were compared against platelet 
count. The result were subjected to statistical analysis. Of the 159 samples 
tested, 17 were positive for one or more dengue parameters . Of the 17, 5 were 
positive for NS1 only, 6 showed IgM only while 1 showed IgG only . More than 
one marker was detected in the remaining 5 samples . Thrombocytopenia was 
more consistently associated whenever NS1 was detected compared to antibody 
detection rate significantly 109. 
¾ In 2013, Muhammad et al did a randomised control trial to find the effectiveness 
of platelet transfusion in dengue fever. Scientific data regarding effects of 
platelet transfusion on platelets transfusion on platelet count in dengue–related 
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thrombocytopenia is scanty. A single centre, randomised non-blinded trial was 
conducted on adult patients with dengue fever and platelet count less than 
30,000/microlitre . Patients were randomised to treatment and control group. 
Treatment group received single donor platelets. Patients with post-transfusion 
platelet increment (PPI>/=10,000/ microlitre and /or corrected count increment 
(CCI) >/=5,000/microlitre 1 hour post transfusion were considered responders. 
Primary outcome was platelet count increments at 24 and 72 hours. 87 patients 
were enrolled, and 43 recieved platelet transfusion .Mean PPI and CCI at 1 hour 
post transfusion in the treatment group were 18,800 /microlitre and 
7000/microlitre respectively. 22  patients in the treatment group   were non-
responders . Mean platelet increments at 24 and 72 higher in the treatment group 
as compared to control group. Responders showed significantly higher 
increments when compared to non-responders and the control group at 24 hours. 
Significant differences were found between non-reponders and the control group 
at 24 hours but not at 72 hours. Patients with lower baseline platelet count were 
more likely to be non responders. Platelet transfusion neither prevented 
development of severe bleeding nor shortened time to cessation of bleeding . 
Three severe transfusion reactions and two deaths occurred in treatment group. 
Platelet transfusion did not prevent development of severe bleeding and was 
associated with  significant side effects . Therefore, platelet transfusion should 
not be routinely done in the management of dengue fever 110. 
¾ In 2013, Tewari  did a study in the clinical profile of dengue fever and use of 
platelets in four tertiary level hospitals of Delhi in the year 2009 . This is 
retrospective study based on the record of 230 patients admitted in 2009 in four 
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tertiary level hospitals situated at different locations in Delhi. 163 cases had 
dengue fever   and 25 cases had evidence of haemorrhagic manifestation. The 
predominant presenting symptoms of dengue syndrome fever cases were that of 
vomiting, pain abdomen, headache, myalgia and nausea . Major bleeding 
manifestation were epistaxis, haematemesis  and malena . Hepatomegaly with 
pleural effusion and ascites was the commonest finding. Severe 
thrombocytopenia as low  as 2000 was observed in cases   of dengue fever and 
another of DHF without any bleeding manifestation in DF and minor bleeding 
manifestations in DHF . Fresh blood has been given to one patient with of DF 
and two patients of DHF. There is significant difference in the value of p in the 
average number of days of stay in hospital for those who are given platelet 
transfusion. Two deaths have been reported in cases of DF –one due to atypical 
presentation, and other due to gastro intestinal bleeding111. 
¾ Vivaldo did a meta-analysis on the diagnostic accuracy of two commercial NS1 
Antigen ELISA tests for early dengue virus detection.  A total of 30 studies 
containing 12,105 total enrolled patients were present in the study. The results 
were as follows 1) Panbio assays showed low performance with sensitivity of 
66% and specificity of 99%. Platelia assays showed higher performance with 
sensitivity of 74% and specificity of 99%. It was found that lowest sensitivity 
values were for secondary infections and was found mainly for DEN4. When it 
came to clinical manifestation the sensitivity of Platelia was found to be 69% for 
fever and dengue haemorrhagic fever. From the above it could be concluded that 
DENV1 gave a higher sensitivity for both of the tests where as DENV4 gave a 
lower sensitivity for the two tests. More over factors such as type of infection, 
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geographical origin of samples and viral serotypes which influences the tests 
require further investigation in order to optimize the diagnosis112.  
¾ Kwissa et al proposed that dengue virus infection induces expansion of a 
CD14(+) CD16(+)  monocyte that stimulates plasma blast differentiation. In this 
study a systems biological approach was used to analyse immune responses to 
dengue in humans. Transcriptomic analysis of whole blood revealed that genes 
encoding proinflammatory mediators and type 1 interferon –related proteins 
were associated with high DENV levels during initial symptomatic disease. 
Additionally, CD 14(+) CD(+) monocytes increased in the blood. This study 
provided a detailed picture of innate responses to dengue and highlight a role for 
CD14(+) CD16(+) monocytes upregulated CD16 and mediated differentiation of 
resting B cells to plasmablasts as well as immunoglobulin and M secretion . 
These findings provide a detailed picture of innate responses to dengue and 
highlight a role for CD14(+) CD (+) monocytes in promoting plasma blast 
differentiation and anti-DENV antibody responses.113       
¾ In 2014, Silva et al used a thiophene-modified screen printed electrode (SPE ) 
for detection of the dengue virus non-structural protein (NS1 ) . A sulphur –
containing heterocyclic compound (thiophene ) was incorporated to a carbon ink 
to prepare prepare reproducible screen printed electrodes. After cured , the 
thiophene SPE was coated by gold nanoparticles conjugated to Protien A to 
form  a nanostructured surface . The Anti-NS1 antibodies immobilized via their 
Fc portions via Protien A, leaving their antigen specific sites free circumventing 
the problem of a random antibodies immobilization .Amperometric responsesto 
the NS1protien of dengue virus were obtained by cyclicvoltammetries   
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performed in presence of ferrocyanide as redox probe. The calibration curve of 
immunosensor showed a linear response from  0.04 microgram/ Litre to 0.6 
microgram/Litre of NS1 with good linear correlation .114 
¾ Arshi etal in 2014 evaluvated the efficacy of various immuochromatographic 
rapid tests for dengue diagnosis . In this study sera from a large number of 
patients admitted to National Institute of Blood Diseases and Bone Marrow 
Transplantation (NIBD) were used to determine the efficacy of NS1 antigen , 
IgA, IgM basedrapid test devices for dengue diagnosis . The dengue NS1 
antigen based device was least efficient while among the antibody based device 
the dengue IgA rapid test was comparatively better. In this study IgA RDT 
could be cost effective and efficient rapid test device for dengue diagnosis.115 
¾ Selvaraj in 2014 did a comparative study between rapid immune 
chromatography  and two enzyme-linked immunosorbent assay kits for NS1 
antigen. In this test the sensitivity and specificity of newly introduced rapid 
combo kit against two conventional ELISA kits is assessed. The performance of 
this kit is quite satisfactory since excellent agreement of 94% was observed with 
particular reference to NS1 antigen detection among all three kits 116. 
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MATERIALS AND METHODS 
 
  The study group consists of all febrile patients with fever of duration less than 
5 days attending the medical OPD for a period of one year from July 2013.  The study 
was done after receiving permission from institutional ethical and research committee.  
A total of 176 blood samples from fever patients were received in the microbiology 
lab of central lab in our institution. Blood from the out patients was collected in the 
microbiology lab whereas from in patients were collected in the ward and then 
transported immediately to the lab .After the arrival of samples in lab an 
immunochromatographic test (card test) for NS1 antigen, IgM and IgG antibodies was 
done by using a kit, of SD BIO LINE purchased from Star laboratories, Nagercoil . 
This was followed by ELISA (Enzyme Linked Immunosorbent Assay) for detection 
of NS1, IgM and IgG antibodies of dengue virus. ELISA was done for all samples 
received in our lab .The ELISA kits were of Panbio purchased  from Star 
Laboratories, Nagercoil.  The other parameters such as age , gender , fever duration 
and platelet count were also recorded. 
INCLUSION CRITERIA 
1) Clinically suspected dengue fever cases 
Cases with fever, headache, retrobulbar pain, pain in the back and the limbs, 
lymphadenopathy, maculopapular rash and any haemorrhagic manifestations. 
2) Patients with day 1 of fever, not possible to correctly fix in every patient. 
EXCLUSION CRITERIA 
1) Those who are unwilling to participate in this study. 
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2) Fever patients found to be positive for other tests such as Widal test ,malarial 
parasites etc  . 
IMMUNOCHROMATOGRAPHIC TEST (CARD TEST) 
SD BIO LINE DENGUE DUO (DENGUE NS1 Ag COMBO) 
 This is a rapid invitro immunochromatographic, one step assay designed to 
detect both dengue virus NS1 antigen and differential IgM/IgG antibodies to dengue 
virus in human serum, plasma or whole blood. The test device contains two test 
devices; 
 1) Dengue NS1 antigen test on the left side  
 2) Dengue IgM/IgG antibodies on the right side  
 The dengue NS1 antigen rapid test in the left side is an in-vitro 
immunochromatographic one step assay designed for the qualitative determination of 
dengue virus NS1 antigen in human serum, plasma or whole  blood. This test device 
contains a membrane strip, which is pre-coated with anti-dengue NS1 antigen capture 
on the test band.   The dengue IgM/IgG rapid test on the right side is a solid phase 
immunochromatographic assay for detection of IgM and IgG antibodies to dengue 
virus in human serum, plasma or whole blood. 
ACTIVE INDREDIENTS OF MAIN COMPONENTS 
SD Bioline Dengue NS1 Ag ;    
 One test strip included; Gold conjugate as the main component: Mouse 
monoclonal anti-dengue NS1 –gold colloid (0.27 +/- 0.05 microgram) 
Test line: Mouse monoclonal anti- dengue NS1 (0.72 +/- 0.14 microgram) 
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Control line: Goat anti-mouse IgG (0.72 +/-0.14 microgram) 
SD BIOLINE DENGUE IgG /IgM  
One test strip; Gold conjugate as the main component: Recombinant Dengue 
envelope protein – gold colloid (1+/- 0.2 micrograms) 
Test line; Mouse monoclonal anti-human IgG (5+/- 1 microgram) 
Control line; Rabbit anti-dengue IgG (2.5 +/-    0.5 micrograms) 
PRINCIPLE 63, 112,113 
 The dengue NS1 antigen test device result window has two pre-coated lines, T 
(NS1 antigen test line) and C (control line). Both the test line and the control line in 
result window are not visible before applying any samples. The control line is used 
for procedural control and should always appear if the test procedure is performed 
correctly. The anti-dengue NS1 antigen-colloid gold conjugate and serum, plasma or 
whole blood move along the membrane chromatographically to the test region (T) and 
forms a visible line as the antibody- antigen –antibody gold particle complex forms.  
             Dengue IgG/IgM test device has three precoated line, G ;( Dengue IgG test 
line), M (Dengue IgM test line) and C (control line) on the surface of the device. All 
the three lines are not visible before applying the sample. Control line should always 
appear if the test procedure is performed properly. A purple G or M lines will be 
visible in the result window if there are enough IgG and/ or IgM antibodies to the 
dengue virus in the sample. When a specimen is added to the sample well, anti-
dengue IgGs and IgMs in the specimen will react with the recombinant dengue virus 
envelope proteins-colloidal gold conjugate and forms a complex of antibodies-
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antigen. As this complex migrates along the length of the test device by capillary 
action, it will be captured by the relevant anti-human IgG and/ or anti-human IgM 
immobilised in two test lines   across the test device and generate a coloured line. 
MATERIALS REQUIRED FOR THE TEST 
1) SD BIO-LINE Dengue Duo kit ;  This kit contains the following items ; 
A) Dengue NS1 antigen and Dengue IgM/IgG combo device 
B) Assay diluents for dengue IgM/IgG test 
C) 10 micro litre capillary pipette for IgM/IgG test  
D) Disposable dropper for NS1 antigen test 
E) A pair of gloves. 
SPECIMEN COLLECTION;   
 Blood was collected by venipuncture after getting the written consent from the 
patient. Whole blood was collected into collection tube containing EDTA and then 
centrifuged at 3000 rpm for about 5-10 minutes to get the plasma which was then 
utilised for the card test. 
KIT STORAGE  
 The kit was stored at a temperature less than 30 degree Celsius in a refrigerator 
and it was never freezed. The shelf life of the kit is indicated on the outer package and 
the tests were performed before the expiry date of the kit. 
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PROCEDURE 
IMMUNOCHROMATOGRAPHIC TEST FOR Dengue NS1 ANTIGEN 
1)  Remove the test device from the foil pouch, and place it on a flat, dry surface. 
2)  With the help of a disposable dropper add 3 drops of specimen in to the sample 
well S. 
3)  Interpret the test result in 15to 20 minutes  
4)  The test was not interpreted after 20 minutes. 
IMMUNOCHROMATOGRAPHIC TEST FOR IgM/IgG ANTIBODIES  
1) With a 10 microlitre capillary pipette  , add 10 microlitre of specimen into the 
square sample well S 
2)  Add 4 drops of assay diluents to the assay diluents well (round shaped) 
3)  Interpret the test result in 15-20 minutes 
ENZYME LINKED IMMUNOSORBENT ASSAY( ELISA ) 
DENGUE EARLY ELISA (Panbio Dengue Early ELISA) 
  Dengue early ELISA is a dengue NS1antigen capture ELISA, which is used for 
qualitative detection of NS1 antigen in serum. 
PRINCIPLE10, 15 
  Serum dengue NS1 antigen, when present, binds to anti-NS1 antibodies 
attached to the polystyrene surface of microwells. Residual serum is removed by 
washing and HRP conjugated Anti-NS1 Mab (Horse radish peroxidise conjugated 
Anti-NS1 monoclonal antibody) is added. After incubation, the microwells are 
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washed and a colourless substrate system, tetramethyl Benzidine /hydrogen peroxide 
(TMB chromogen) is added. The substrate is hydrolysed by the enzyme and the TMB 
changes to blue colour .After stopping the reaction with the acid, the TMB turns 
yellow. Colour development is indicative of the presence of dengue NS1 antigen in 
the test sample. 
Materials required for Early Dengue ELISA  
1) Anti-NS1 Antibody Coated Microwells (12x8 wells ) ; microwells are coated 
anti-NS1 antibodies  
2) HRP conjugated Anti-NS1 Mab ( Horse radish peroxidise conjugated Anti-NS1 
monoclonal antibody with preservative ) ;one bottle 15 ml ( orange colour ). 
The preservative used is 0.1% Proclin. 
3) Wash buffer; one bottle, 60ml of 20x concentrate of phosphate buffered saline 
(pH 7.2-7.6) with Tween20 and preservative. Dilute one part wash buffer with 
19 parts of distilled water. Diluted buffer may be stored for one week at 2-25 
0C. Crystallisation may occur at low temperatures which may be corrected by 
incubation at 370C until clear. 
4) Sample diluent ; One bottle of sample diluent  , 22 ml  (brown colour). Ready 
for use. It consists of Tris buffered saline   with preservative (o.1% Proclaim) 
and additives.  The sample diluents remains stable at 2-80C until expiry. 
5) TMB Chromogen; one bottle 15 ml ready for use. A mixture of 3, 3, 5, 5,-
tetramethyl Benzidine and  hydrogen peroxide in a citric acid citrate buffer. 
TMB chromogen   is stable at 2-80C and can be used until expiry . 
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6) Positive control; one purple capped vial, 1.2 ml recombinant antigen  
7) Calibrator ; Two orange –capped vials , 1.5 ml recombinant antigen  
8) Negative control ; one white –capped vial , 1.2 ml human serum  
  The two controls and the calibrator are stored at 2-80C until expiry  
9) Stop solution ; one red capped bottle , 15 ml ready for use, 1M phosphoric acid.  
Stop solution  can be stored at 2-80C until expiry. 
10) Adjustable micropipettors with disposable pipette tips (5-1000 microlitre 
capacity). 
11) Deionised water. 
12) Microplate washing system. 
13) Micro plate reader as possible reader with 450 nm filter. 
14) Timer. 
15) Graduated cylinder. 
16) Flask. 
17) Test tubes  
Specimen  
 The serum was separated as soon as blood was received in the lab and stored at 
2-8 degree Celsius. 
TEST PROCEDURE 
1)  All the reagents were equilibrated to room temperature before commencing the 
assay. 
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2)  Required number of microwells was removed from the foil sachet. 
3)  Five microwells are required for positive control (P), Negative control (N) and 
Calibrator (CAL) in triplicate. 
4)  Using suitable test tubes or a microtitre plate, dilute the positive control, 
negative control, and calibrator and patient samples. 
5) Add 75 microlitres of sample diluents to 75 microlitre of the sample and mix 
well. 
6)  Pipette out 100 microlitres of diluted test samples and controls into their 
respective micro wells. 
7)  Cover plate and incubate for one hour at 37 +/- 10C. 
8)  Wash six times with diluted wash buffer. 
9)  Pipette 100 microlitre HRP conjugated Anti-NS1 Mab into each well. 
10)  Cover the plate and incubate for one hour at 37 +/- 10C 
11)  Wash six times with diluted wash buffer. 
12)  Pipette 100 microlitre of TMB into each well. 
13)  Incubate at room temperature for 10 minutes. A blue colour will develop. 
14)  Pipette 100 microlitre of stop solution to all wells  in the same sequence and 
timing as the TMB addition. The blue colour will change to yellow. 
15)  Within 30minutes the absorbance of each well is read at a wavelength of 450 
nm with a reference filter of 600-650 nm. 
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QUALITY CONTROL 
 Each kit contains calibrator, positive and negative controls. Acceptable values 
for these were found on the accompanying specification sheet .The negative and the 
positive controls are intended to monitor for substantial reagent failure. The test was 
considered invalid and was repeated if the absorbance readings of either controls or 
the calibrator do not meet the specifications. 
CALCULATIONS 
1) The calibration factor is batch specific and was obtained from the specification 
sheet before commencing the calculations  
2) Cut off value; it is the average absorbance of the calibrator triplicates 
multiplied by   the calibration factor. 
3) Index value ; Sample absorbance / Cut off value  
4) ELISA units can be calculated by multiplying the index value by 10. 
INTERPRETATION OF THE RESULTS 
INDEX ELISA UNITS (Panbio units) RESULT 
<O.9 <9 NEGATIVE 
0.9-1.1 9-11 EQUIVOCAL 
>1.1 >11 POSITIVE 
 
RESULT INTERPRETATION 
Negative No detectable dengue NS1 antigen  
Equivocal  Equivocal samples were repeated 
Positive  Presence of detectable dengue NS1 
antigen  
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DENGUE IgM CAPTURE  ELISA 
 The dengue IgM Capture ELISA is used for qualitative detection of IgM 
antibodies to dengue antigen in the serum. 
PRINCIPLE 54,55,69 
  Serum antibodies of the IgM class when present combines with anti-human IgM 
antibodies attached to the polystyrene surface of the microwell test strips. A 
concentrated pool of dengue 1-4 antigens is diluted to the correct working volume 
with antigen diluents. The antigens are produced using an insect cell expression 
system and immunopurified utilising a specific monoclonal antibody. An equal 
volume of the HRP Conjugated Monoclonal antibody (Mab) is added to the diluents 
antigen, which allows the formation of antigen- Mab complexes. Residual serum is 
removed from the assay plate by washing, and the complexed antigen –Mab is added 
to the assay plate. After incubation, the microwells are washed and a colourless 
substrate system, tetramethylbenzidne /hydrogen peroxide (TMB Chromogen) is 
added. The substrate is hydrolysed by the enzyme and the chromogen changes to blue 
colour. After stopping the reaction with the acid, the TMB becomes yellow .Colour 
development is indicative of the presence of anti-dengue IgM antibodies in the test 
sample. 
MATERIALS REQUIRED FOR DENGUE IgM CAPTURE ELISA; 
Materials provided in the kit are; 
1) Anti-human coated microwells-(12x8); Microwells are coated with anti-human 
IgM antibodies 
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2) Dengue 1-4 Antigens (Recombinant); one clear capped vial, 150 microlitres 
(blue), concentrated dengue viral antigens 1, 2, 3, 4 . Unused diluted antigen 
must be discarded. Concenterated antigen is stored at 2-80C until expiry . 
3) Wash buffer;  one bottle , 60ml of 20x concentrate of phosphate buffered saline 
( pH 7.2-7.6 )with Tween 20 and preservative (0.1% Proclin) Crystallisation 
may occur at low temperatures . To correct , wash buffer is incubated at 370C 
until clear  .  Dilute one part wash buffer with 19 parts  of distilled water  . 
Diluted  buffer  may be stored for one week at 2-25 0C. 
4) Sample Diluents; Two bottles, 50ml (pink) ready-to use. Tris  buffered saline . 
(Ph; 7.2-7.6) with preservative  (0.1%  Proclin ).and additives . It is stable at 2-
80C  until expiry.     
5)           Antigen Diluents ; One bottle , 50ml (clear ) . Ready for use , Phosphate 
buffer  containing preservative ( 0.1% Proclin  and 0.005% gentamycin ). It is 
stored at 2-80C until expiry. 
6) HRP Conjugated Monoclonal Antibody Tracer; one bottle 7 ml (yellow) . 
Ready for use . Horse radish peroxidise   conjugated monoclonal antibody 
tracer.  . Stable at 2-80C until expiry with added protein stabilisers and 
preservative (0.1% Proclin ). 
7) TMB Chromogen ( Tetramethyl benzidine chromogen );one bottle 15 ml ready 
for. It is a mixture of 3,3,, 5,5, -tetramethylbenzidine and hydrogen peroxide in 
a citric acid citrate  buffer  (Ph 3.5-3.8) .  Stable at 2-8 0C until expiry. 
8) Positive control; One Black capped vial containing 200 microlitre human 
serum ( containing 0.1% sodium azide and  0.005% gentamycin sulphate ).   
Stable at 2-8 0C until expiry. 
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9) Calibrator ; One orange – capped vial , 400 microlitre human serum (containing 
o.1% sodium azide and 0.005% gentamycin sulphate ). Stable at 2-8 0C until 
expiry. 
10) Negative control; One white capped vial , 200 microlitre of human serum  
(contains 0.1% sodium azide and 0.005% gentamicin sulphate ). Stable at  
 2-8 0C.  
11) Stop solution; One red capped bottle , 15 ml , Ready for use ( 1M phosphoric 
acid). Stable at 2-25 0C until expiry. 
Additional materials required are ; 
12) Accurate adjustable micropipettors with disposable pipette tips (5-1000 
microlitre capacity ) 
13) Deionised water. 
14) Microplate washing system. 
15) Microplate reader with 450nm filter. 
16) Timer. 
17) Graduated cylinder. 
18) Flask. 
19) Test tubes  
20) Glass  or plastic tubes or vials . 
PROCEDURE 
 Before commencing the test procedure , ensure all the reagents are equilibrated 
to the room temperature. 
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1) Remove the required number of microwells from the foil sachet . Five 
microwellsare required for Negative control (N), Positive control (P), and 
Calibrator (CAL) in triplicate. Remaining unused microwells were sealed 
tightly in the foil sachet. 
2) Using test tubes   positive control, negative control , calibrator and patient 
serum were diluted . 
3) Serum Dilution;  To 10 microlitre serum add 1000 microlitre of sample diluents 
and mix well. 
4) Antigen was diluted 1/250 using  the antigen diluents. As per the kit , 10 
microlitre of the antigen was diluted into 2.5 ml of antigen diluents. A volume 
of 2.5 ml of diluted antigen is required strip. The remaining unused 
concentrated antigen was stored at a temperature of 2-8 degree Celsius. 
5) Required volume of diluted antigen was mixed with an equal volume of Mab 
Tracer in a clean  vial , gently mixed and left  at room temperature . 
6) Assay plate; Within 10 minutes after mixing the Mab tracer and diluted 
antigen, pipette 100 microltre diluted patient sample and controls into their 
respective microwells of the assay plate . 
7) Cover the plate and incubate for 1 hour at 370C. 
8) Wash six times with diluted wash buffer. 
9) Antigen-MAb tracer solution was mixed and 100 microlitre of antigen-MAb 
complex was transferred from antigen vial to the appropriate wells of the assay 
plate. 
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10) The plate was covered with  a foil paper and incubated  for 370C. 
11) The wells were washed six times with diluted wash buffer . 
12) 100 microlitre of TMB was transferred into each well and then incubated for  
10 minutes at room  temperature . A blue colour will develop .  
13) Pipette  out 100 microlitre of stop solution into all wells in the same sequence 
and timing as the TMB solution and mixed well . Then blue colour will change 
to yellow colour. 
14) The absorbance of each well at a wavelength of 450 nm is read. 
QUALITY CONTROL 
 Each kit contains calibrator, positive and negative controls. Acceptable values 
for these were found on the accompanying specification sheet .The negative and the 
positive controls are intended to monitor for substantial reagent failure. The test was 
considered invalid and was repeated if the absorbance readings of either controls or 
the calibrator do not meet the specifications. 
CALCULATIONS 
1) The calibration factor is batch specific and was obtained from the specification 
sheet before commencing the calculations  
2) Cut off value; it is the average absorbance of the calibrator triplicates 
multiplied by   the calibration factor . 
3) Index value ; Sample absorbance / Cut off value  
4) ELISA units can be calculated by multiplying the index value by 10. 
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INTERPRETATION OF THE RESULTS 
INDEX ELISA UNITS(PANBIO 
UNITS) 
RESULT 
<O.9 <9 NEGATIVE 
0.9-1.1 9-11 EQUIVOCAL 
>1.1 >11 POSITIVE 
 
RESULT INTERPRETATION 
Negative No detectable dengue IgM antibody  
Equivocal Equivocal samples were repeated 
Positive Presence of detectable dengue IgM antibody. 
 
DENGUE  IgG  CAPTURE ELISA 56,60 
 The  Dengue IgG ELISA is used for the qualitative presumptive detection of 
elevated IgG antibodies to dengue virus in patients with secondary infection 
PRINCIPLE  
  Serum antibodies of the IgG class when present combines with anti-human IgM 
antibodies attached to the polystyrene surface of the microwell test strips . A 
concentrated pool of dengue 1-4 antigens is diluted to the correct working volume 
with antigen diluents. The antigens are produced using an insect cell expression 
system and immunopurified utilising  a specific monoclonal antibody . An equal 
volume of the HRP Conjugated Monoclonal antibody (Mab )is added to the diluents 
antigen, which allows the formation of antigen- Mab complexes . Residual serum is 
removed from the assay plate by washing , and the complexed antigen –Mab is added 
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to the assay plate. After incubation , the microwells are washed and a colourless 
substrate system , tetramethylbenzidne /hydrogen peroxide (TMB Chromogen )is 
added . The substrate is hydrolysed by the enzyme and the chromogen changes to blue 
colour . After stopping the reaction with the acid , the TMB becomes yellow .Colour 
development is indicative of the presence of anti-dengue IgG antibodies in the test 
sample . 
MATERIALS REQUIRED FOR Dengue IgG  CAPTURE ELISA  
 Materials provided in the kit are; 
1) Anti-human coated microwells-(12x8); Microwells are coated with anti-human 
IgG  antibodies 
2) Dengue 1-4 Antigens (Recombinant); one clear capped vial , 150 microlitre  
(red), concentrated dengue viral antigens 1, 2, 3, 4. Unused diluted antigen 
must be discarded.  Concenterated antigen is stored at 2-80C until expiry. 
3) Wash buffer;  one bottle, 60ml of 20x concentrate of phosphate buffered saline 
(pH 7.2-7.6 )with Tween 20 and preservative (0.1% Proclin ) The wash buffer 
is to be diluted, that is one part of wash buffer with 19 parts of distilled water  . 
Diluted buffer may be stored at 2-25 0C for one week. 
4) Sample Diluent; Two bottles, 50ml (pink) ready-to use. Tris buffered saline 
pH7.2-7.6 with added   preservative (0.1% Proclin) and additives. Stable at 2-
80C until expiry. 
5) Antigen Diluent; One bottle, 50ml (clear ) . Ready for use, Phosphate buffer 
containing preservative (0.1% Proclin and 0.005% gentamycin ) . It is stored at 
2-8 0C until expiry. 
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6) HRP Conjugated Monoclonal Antibody Tracer; one bottle 7 ml (green ) . 
Ready for use. Horse radish peroxidise conjugated monoclonal antibody tracer 
with added preservatives  and  protein stabilisers. Stable at 2-80C until expiry. 
7) TMB Chromogen (Tetramethyl benzidine chromogen );one bottle 15 ml ready 
for use . A mixture of 3, 3,,5,5,-tetramethyl benzidine and hydrogen peroxide in 
a citric acid citrate buffer.  Stable at 2-80C until expiry. 
8) Reactive  control ; One red  capped vial containing 200 microlitre human serum 
(containing 0.1% sodium azide and .005% gentamycin sulphate ). Stable at  
2-80C until expiry. 
9) Calibrator; One yellow – capped vial, 400 microlitre human serum (containing 
0.1% sodium azide sulphate). Stable at 2-80C until expiry. 
10) Negative control; one green capped vial, 200 microlitre human serum (contains 
0.1% sodium azide and .005% gentamycin sulphate). Stored at 2-8 0C until 
expiry. 
11) Stop solution;  One red capped bottle, 15 ml, Ready for use (1M phosphoric 
acid). Stable at 2- 25 0C until expiry. 
Additional materials required are ; 
12) Accurate adjustable micropipettors with disposable pipette tips (5-1000 
microlitre capacity ) 
13) Deionised water. 
14)   Microplate washing system. 
15) Microplate reader with 450nm filter. 
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16) Timer. 
17) Graduated cylinder. 
18) Flask. 
19) Test tubes  
20) Glass  or plastic tubes or vials . 
PROCEDURE 
 Before commencing the test procedure, ensure all the reagents are equilibrated 
to the room temperature. 
1)  Remove the required number of microwells from the foil sachet. Five 
microwells are required for Negative control (N), Positive control (P), and 
Calibrator (CAL) in triplicate. Remaining unused microwells were sealed 
tightly in the foil sachet. 
2) Using test tubes positive control, negative control, calibrator and patient serum 
were diluted. 
3) Serum Dilution; To 10 microlitre serum add 1000 microlitre of sample diluents 
and mix well. 
4) Antigen was diluted 1/250 using the antigen diluents. As per the kit , 10 
microlitre of the antigen was diluted into 2.5 ml of antigen diluents. A volume 
of 2.5 ml of diluted antigen is required strip. The remaining unused 
concentrated antigen was stored at a temperature of 2-80C. 
5) Required volume of diluted antigen was mixed with an equal volume of Mab 
Tracer in a clean vial, gently mixed and left room temperature . 
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6) Assay plate; Within 10 minutes after mixing the Mab tracer and diluted 
antigen, pipette 100 microltre diluted patient sample and controls into their 
respective microwells of  the assay  plate . 
7) Cover the plate and incubate for 1 hour at 370C. 
8) Wash six times with diluted wash buffer. 
9) Antigen-MAb tracer solution was mixed and 100 microlitre of antigen-MAb 
complex was transferred from antigen vial to the appropriate wells of the assay 
plate. 
10) The plate was covered with  a foil paper and incubated  for 37 degree Celsius 
11) The wells were washed six times with diluted wash buffer  
12) 100 microlitre of TMB was transferred into each well and then incubated for  
10 minutes at room  temperature . A blue colour will develop .  
13) Pipette out 100 microlitre of stop solution into all wells in the same sequence 
and timing as the TMB solution and mixed well . Then blue colour will change 
to yellow colour. 
14) The absorbance of each well at a wavelength of 450 nm is read. 
QUALITY CONTROL 
 Each kit contains calibrator , positive and negative controls. Acceptable values 
for these were found on the accompanying specification sheet .The negative and the 
positive controls are intended to monitor for substantial reagent failure . The test was 
considered invalid and was repeated if the absorbance readings of either controls or 
the  calibrator do not meet the specifications. 
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CALCULATIONS 
 The calibration factor is batch specific and was obtained from the specification 
sheet before commencing the calculations  
Cut off value; it is the average absorbance of the calibrator triplicates multiplied by   
the calibration factor. 
Index value; Sample absorbance / Cut off value  
ELISA units can be calculated  by multiplying the index value by 10. 
INTERPRETATION OF RESULTS 
INDEX ELISA UNITS(Panbio 
units ) 
RESULT 
<1.8 <18 NEGATIVE 
1.8-2.2 18-22 EQUIVOCAL 
>2.2 >22 POSITIVE 
 
 
RESULT INTERPRETATION 
Negative No detectable dengue IgG antibody  
Equivocal Equivocal samples were repeated 
Positive Presence of detectable dengue IgG antibody. 
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RESULTS 
 
The study was done using multi variant regression analysis with dependent 
binary variables. This model also assumes that Z is linearly related to the 
predictors.114,115 
zi=b0+b1xi1+b2xi2+...+bpxip  
Where 
xij is the jth predictor for the ith case
bj is the jth coefficient 
p is the number of predictors 
 Z is a binary variable which takes value 1 for positive sample and zero for 
negative sample 
 
 
 
 
 
 
 
Results 
 85 
 
 
 
 
 
Table1                 NS1 ANTIGEN CARD TEST 
Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 
Step 
1(a) 
platelet 
.0001 .000 30.337 1 .0001* 1.000 
  age .012 .030 .154 1 .695 1.012 
  Gender -.280 .626 .200 1 .655 .756 
  days -1.476 .328 20.272 1 .0001* .228 
  Constant 7.719 1.913 16.285 1 .000* 2250.847 
A  Variable(s) entered on step 1: platelet, age, Gender, days 
• P value of platelet count is 0.0001 . Since p value is less than 0.05 , association 
between platelet count and NS1 antigen is significant. 
• P value of fever duration is less than 0.05  There is association between fever 
duration and NS1 antigen.. 
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Table2;              IgM CARD TEST 
                         Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 
Step 
1(a) 
platelet 
.000 .000 5.606 1 .018* 1.000 
  age .089 .045 3.900 1 .048* 1.093 
  Gender .074 .869 .007 1 .932 1.077 
  days .868 .384 5.108 1 .024* 2.383 
  Constant -6.856 2.509 7.467 1 .006 .001 
A  Variable(s) entered on step 1: platelet, age, Gender, days. 
 
• The p value for platelet count, age  and  duration of fever is less than 0.05%  . 
Hence there is association between these three parameters and IgM card test. 
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Table3;             NS1 ANTIGEN ELISA (PANBO UNITS) 
                      Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 
Step 
1(a) 
Platelet 
.000 .000 30.337 1 .0001* 1.000 
  Age .012 .030 .154 1 .695 1.012 
  Gender -.280 .626 .200 1 .655 .756 
  Days -1.476 .328 20.272 1 .0001* .228 
  Constant 7.719 1.913 16.285 1 .000* 2250.847 
A  Variable(s) entered on step 1: platelet, age, and Gender days of fever 
 
The p value of  platelet count and duration of fever is less than 0.05 % . Hence 
there is association between NS1 ELISA  and platelet and fever duration . 
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Table4;                IgM ELISA (PANBI-O UNITS) 
                       Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Step 
1(a) 
Platelet 
.000 .000 7.281 1 .007* 1.000 
  Age .020 .020 .963 1 .327 1.020 
  Gender .275 .392 .491 1 .484 1.316 
  Days .598 .179 11.138 1 .001* 1.818 
  Constant -2.903 1.098 6.986 1 .008* .055 
A  Variable(s) entered on step 1: platelet, age, Gender, days. 
 
The p value of platelet count , duration of fever  is less than 0.05% . Hence 
there is association between IgM  ELISA  and the above two parameters. 
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 Table5                   IgG ELISA (PANBIO- UNITS) 
 Variables in the Equation 
 
  B S.E. Wald df Sig. Exp(B) 
Step 
1(a) 
Platelet 
.000 .000 4.012 1 .045* 1.000 
  Age -.030 .041 .551 1 .458 .970 
  Gender -.198 .819 .059 1 .809 .820 
  Days .301 .398 .572 1 .449 1.351 
  Constant -7.213 3.239 4.959 1 .026* .001 
A  Variable(s) entered on step 1: platelet, age, Gender, days. 
 
Here the p value of platelet count is only less than 0.05%. platelet count is 
associated with IgG ELISA. 
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Table 6,                    NS1 ANTIGEN CARD TEST 
  
Frequency Percent Valid Percent
Cumulative 
Percent 
Valid Negative 119 67.6 67.6 67.6 
Positive 57 32.4 32.4 100.0 
Total 176 100.0 100.0  
 
The above table shows the frequency of NS1 antigen immunochromatographic 
test . The frequency of NS1 antigen immunochromatographic  positive samples is 57 
(32.4%) and the frequency of NS1 antigen immunochromatographic   negative 
samples is 119 (67.6%) ( Fig;4) 
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Table 7 ,                 IgM CARD TEST 
  
Frequency Percent Valid Percent
Cumulative 
Percent 
Valid Negative 169 96.0 96.0 96.0 
Positive 7 4.0 4.0 100.0 
Total 176 100.0 100.0  
 
The above table shows the frequency of IgM card test . The frequency of IgM 
card positive samples is 7 (4%) and the frequency of IgM card negative samples is 
169 (96%). (Fig;5 ) 
 
 
 
Table 8,      IgG CARD TEST 
  
Frequency Percent Valid Percent
Cumulative 
Percent 
Valid Negative 176 100.0 100.0 100.0 
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Table 9,    NS1 ANTIGEN ELISA PANBI-O UNITS 
 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Negative 119 67.6 67.6 67.6 
Positive 57 32.4 32.4 100.0 
Total 176 100.0 100.0  
 
  The above table shows the frequency of NS1 antigen ELISA samples.  The 
frequency of NS1 antigen ELISA positive samples is 57 (32.4%) and the frequency of 
NS1 antigen ELISA negative samples is 119 (67.6%).(Fig 6) 
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Table 10;      IgM ELISA PANBIO UNITS 
  
Frequency Percent Valid Percent
Cumulative 
Percent 
Valid Negative 139 79.0 79.0 79.0 
Positive 37 21.0 21.0 100.0 
Total 176 100.0 100.0  
 
The above figure shows the frequency of IgM ELISA . The frequency of IgM 
ELISA positive samples is 37 (21%) and the frequency of IgM ELISA negative 
samples is 139(79%) (.Fig 7) 
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Table 11 ;                IgG ELISA PANBIO UNITS 
 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Negative 168 95.5 96.0 96.0 
Positive 7 4.0 4.0 100.0 
Total 175 99.4 100.0  
Missing System 1 .6   
Total 176 100.0   
 
The above figure shows the frequency of IgG ELISA . The frequency of IgG 
ELISA positive samples is 7 (4%) and the frequency of IgG ELISA negative samples 
is 168 (95.5%).(Fig 8)  
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 Fig 4, The above figure shows the frequency chart for NS1 antigen 
immunochromatographic test. The frequency of NS1 antigen card negative samples is 
found to be 119 (67.6%) and the frequency of positive samples is 57(32.4%)  (Table 
6) 
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 Fig5, The above figure shows the frequency distribution of IgM 
immunochromatographic test. The frequency of IgM card negative samples  is 
169(96%)  and the frequency of IgM card positive  samples is 7 (4%). [Table7] 
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 Fig 6, The above figure shows the frequency chart for NS1 antigen ELISA. 
The frequency of NS1 antigen ELISA  negative  samples is 119 (67.6%) and the 
frequency of NS1 antigen ELISA  positive  samples is 57(32.4%). [Table 9] 
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  Fig 7, The above figure shows the frequency chart for IgM ELISA . The 
frequency of IgM ELISA positive samples is 37 (21%) and the frequency of IgM 
ELISA negative samples is 139 (79%) .[Table 10] 
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 Fig 8,   The above figure shows the frequency chart for IgG ELISA . The 
frequency of IgG ELISA negative samples is 168(95.5%) and  the frequency of  IgG 
ELISA positive samples is 7 (4%). [Table 11] 
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DISCUSSION 
                         
  Dengue fever is an important mosquito borne viral disease of humans . The 
disease is now present in more than hundred countries in Africa ,  America , Eastern 
Mediterranean , Western Pacific , and particularly in South East Asia.  approaches had 
been applied for diagnosing dengue virus infection22 . These methods include 
detection of the virus (by cell culture, immunofluorescence), detection of virus 
antigen (by enzyme linked immunosorbent assay, ELISA), detection of anti-dengue 
virus antibody [by haemagglutination Inhibition, (HI),  complement  fixation (CF), 
neutralisation tests, ELISA ] and detection of viral  nucleic acid by reverse 
transcriptase polymerase chain rection. However for confirmed dengue diagnosis 
dengue virus should be identified by isolation or nucleic acid detection or there should  
be a fourfold rise in antibody titre in  paired sera  in patients presenting with signs and 
symptoms consistent with dengue virus infection102 .  
  The study was conducted at Sree Mookambika Institute of Medical Science , 
Kulasekharam  for  one  year  from July 2013.  Blood samples from 176 clinically 
suspected cases of dengue infection (according to WHO criteria )  with fever of 
duration less than 5 days were  taken after receiving  a written  consent  from the 
patient . Out of total 176 serum samples, 101   were positive for dengue  seromarkers .  
The dengue seromarkers used in this study were   NS1antigen , IgM  and  IgG  
antibodies. Two methods were employed in the study; a Rapid  
immunochromatographic test  (card test ) and ELISA . The tests were done for each of 
the dengue seromarkers.  In addition to these specific markers, age gender, fever 
duration  and  platelet count  were   recorded  for  each patient. 
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Table 12. Comparison of efficacy of various dengue specific seromarkers  in the 
diagnosis of dengue infection   
DENGUE 
SEROMARKERS 
CARD TEST POSITIVE ELISA POSITIVE 
NS1antigen 57(32%) 57(32%) 
IgM antibody 7(4%) 37(21%) 
IgG antibody 0 7(4%) 
 
 The distribution of various specific dengue parameters is shown in table 12. 
Out of 176 cases, 57 (32%) were positive only for NS1 antigen [Table 6&9]. 
Considering a very high sensitivity of NS1 it can be stated that  , the diagnosis in 32% 
of cases would have been missed if NS1 was not included in the test panel.  Kulkarni 
(2011) ,  Shrivastva(2011 ) ,  Datta(2010)  have shown that NS1 was positive in 95  
out of 320 cases (30%), 15 out of 91 cases (16%) and 140 out of 600 cases (23%) 
respectively in their studies1 . From the above it can be said that a large number of 
cases would be missed  if NS1 antigen is not included in the test panel for dengue 
virus infection detection. Those who are exclusively NS1 positives could be offered 
appropriate supportive therapy, thus avoiding any irrational use of  antibiotics . The 
patients and their attendants could be briefed regarding the basics of vector biology 
and provided with mosquito nets during viraemic phase to further prevent the spread 
of infection to others.  The dengue specific antibodies appear only by third to fifth day 
of fever in primary dengue infection2 . Even in most secondary infections, both IgM 
and IgG type antibodies cannot be recorded before the third day. Both in primary and 
secondary dengue infection there is always a window period, both in primary when 
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only antibodies are detected. Moreover the utility of antibody relies mainly on the 
rising titres especially in endemic areas. The seromarker NS1 antigen which is a 
highly sensitive  dengue marker for dengue infections is  detected from the first day of 
fever .  Among the 57 NS1 antigen positive cases 28 (49%) were detected on the 
second day of fever  . This is in accordance with a study conducted by Hang etal 
(2008). The study reported the diagnostic accuracy of NS1 ELISA and lateral flow 
rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody 
responses.  According to the study the sensitivity of both ELISA and NS1 – Lateral 
flow rapid tests were influenced by the patients duration of fever before entering the 
study. The tests were significantly more sensitive when the test samples were 
collected within 3 days of illness onset. If NS1 is positive, the right intervention could 
be initiated. 
 Following the initial infection, the dengue virus replicates to high titres in the 
blood before the patient becoming symptomatic enough to go to a physician. During 
the viraemic phase of dengue infection, NS1 antigen are produced  during virus 
replication in either membrane associated or secreted forms. Soluble NS1 circulates in 
the serum of patients  of these patients and thus provides an excellent tool  for 
diagnosis of acute dengue infections11.  
 In this study ELISA is taken as the gold standard  for serological testing of 
dengue fever. From the table 6, it could be shown that , NS1antigen was positive in 57 
/ 176(  32%) cases by immunochromatographic test.  These 57 cases (32%) were also 
found to be positive for ELISA and those cases which were found to be negative by 
card test were found to be negative  by ELISA. Thus it could be shown that the rapid 
immunochromatographic test used in this study is equally sensitive and specific to 
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ELISA. Although virus isolation is considered to be the gold standard for laboratory 
diagnosis of dengue viral infections , it involves large labour and requires at least 6-10 
days for virus to replicate1,15 . On the other hand RT-PCR  is expensive and require 
sophisticated infrastructure , technically skilled manpower which are not available in 
most of the hospitals . With increasing incidence of dengue infections, the early 
diagnostic confirmation is required for timely intervention   and disease control . 
Hence, diagnosis of dengue disease during the acute phase should be the priority and 
is a public health concern.  In a developing country like India where resources are 
minimal a Rapid immunochromatographic test method could be useful as a point of 
care test to provide early diagnosis for timely intervention48. 
 In the study 7 cases  (4%)  out of  176 were  IgM positive   by 
immunochromatographic test [Table7]   .  By  ELISA method  a total of 37 (21%) out 
of 176 cases were positive for IgM   .This 37 cases included 7 cases which were IgM  
positive  by immunochromatographic test .So all the IgM  positive cases detected by 
Immunochromatographic test were  positive by ELISA also . Additionally 30 samples 
were detected as IgM  positive by ELISA method.  Here we can see that these patients 
may have presented in the later stage of the primary infection by dengue virus.  In 
addition, IgM  antibody response varies considerably among individuals due to host 
humoral immune response.   By immunochromatographic test , no samples was found 
to be positive by IgG but by ELISA 7 (4% ) were detected as IgG positive. So we can 
see that these seven IgG  positive patients may have  presented during their secondary 
infection.  A high level of IgG is an indicator of infection or it represents 
endemicity54.  A high degree of cross reactivity is mostly observed in flavivirus 
infection  because the flaviviruses share common group epitopes particularly on the 
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envelope (E) protein44.  The dengue serological tests become more difficult, because 
dengue antibodies are cross reactive with other  flaviviruses  such as West Nile virus 
(WNV), Japanese encephalitis  virus (JEV)  and Yellow fever virus (YFV).  Moorthy 
(2009) has evaluated a rapid immunochromatographic device for detection of IgM  
and IgG antibodies to dengue viruses done in tertiary care hospital . Accuracy indices 
for IgM and IgG detection respectively were   positive predictive value of 61% and 
72% and negative predictive value of 89% and 83% respectively . it was concluded 
that the device performs poorly in the detection of IgM and IgG  antibodies to dengue 
virus  and is not recommended for use as a stand –alone diagnostic test80.  
 In this study an attempt has been made to find out the association of dengue   
serological marker with thrombocytopenia .  Platelet count less than 1oo,ooo/ml is 
taken as thrombocytopenia. Out of the 176 cases 123 cases (70%) has shown 
thrombocytopenia .The comparison of platelet counts with dengue specific parameters 
is shown in table 7. Out of the 57 cases positive for NS1 antigen ,  thrombocytopenia 
was evident in 42 cases (74%). In contrast , when IgM and IgG antibodies were 
compared  only 20 (45%) out of 44 cases had thrombocytopenia. Therefore early 
viraemic phase coincides with high NS1 antigen levels in the blood which in turn is 
related to thrombocytopenia1. 
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Table13. Comparison of platelet counts with various permutations and combinations 
of dengue parameters. 
SEROLOGICAL 
MARKERS 
TOTAL PLATELET COUNT 
LESS THAN 
100,000ML 
PERCENTAGE
NS1 antigen 57 42 74% 
IgM antibody 37 18 48% 
IgG antibody 7 2 28% 
 
 From the above table it can also be observed that , thrombocytopenia is 
observed in 48% of IgM antibody positive cases and 28% of the IgG positive cases. 
Association of thrombocytopenia with NS1 was found to be higher by statistical test  ( 
Table 1, 3) ; Multivariant Regression Analysis with dependent binary variables . The 
p value has been found to be less than .05 (p < 0.05 ) which is found to be highly  
significant.  From the above results it could  be concluded that thrombocytopenia is 
more commonly associated with NS1 antigen positive cases than NS1 negative cases.  
Association of thrombocytopenia with NS1was found to be 74%  while association of 
thrombocytopenia with IgM and IgG was found to be 50%.  Association of 
thrombocytopenia with IgM is found to be significant  ( p value= 0.018) whereas not 
much association is found between thrombocytopenia and IgG  levels ( p value 
=0.045)  ( Table 2, 5 ). The mechanism of dengue related thrombocytopenia and 
coagulopathy is quite complex . So viraemia correlates with NS1 positivity and 
thrombocytopenia. It would involve platelet activation , pro-coagulant and 
anticoagulant arms of the coagulation system , complement , cytokines , and 
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endothelial cells . Moreover symptomatic thrombocytopenia would require platelet 
transfusion though platelet counts might not correlate well with clinical bleeding11 .  
              Saurabh (2013) studied the importance of platelet count and   serological 
markers in diagnosing dengue infection  .  Of the 159 samples tested , 17 were 
positive for one or more dengue parameters . Of the seventeen  , 05 were positive for 
NS1 only , 06  showed IgM only while 01 showed IgG only  . Thrombocytopenia was 
more consistently associated whenever NS1 was detected compared to  antibody 
detection109 . 
        In the present study 75 cases of fever , in which none of the dengue parameters 
was positive , thrombocytopenia was noted in 22 cases . Platelets are decreased  in 
several other conditions like some viral infections other than dengue , drug induced 
thrombocytopenia , collagen vascular diseases, idiopathic thrombocytopenia  etc1 .   
 This study is  conducted in a tertiary care teaching hospital which lack a viral 
culture set up . Therefore applying gold standard tests in the studies related to viral 
infection is not practical for diagnosis and treatment purpose .   The precise day of 
fever at the time of conducting the test could not be obtained in a large number of 
cases.  NS1 antigen was positive in 32% of cases  by both tests.  It  indicates that if 
the samples were taken on the first day of fever  more number of cases would have 
been picked up by NS1 antigen57 . It is shown that the titres of NS1 represents the 
viral load and the viral load is directly proportional to the complications. 
Conventional ELISA require at least 4 hours whereas rapid immunochromatographic 
test requires twenty  minutes, which will be helpful in initiating the treatment and 
minimizing the complications and mortality of dengue120. But the lack of conformity 
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in the evaluvation of Dengue rapid diagnostic tests  ( RDTs ) remains a problem and a 
standardised approach must be performed when performing diagnostic assessment . 
Moreover studies have demonstrated that Rapid diagnostic test cannot reliably 
differentiate the different dengue infection states ( primary or secondary dengue 
infection).   The manufacturers of the kit used in this study allows the use of serum , 
plasma or whole blood for use in dengue rapid diagnostic tests1 . Unfortunately there 
is little evidence that all sample types perform equally well . The effect  of  
anticoagulants and whole blood on RDT performance and ease of reading also require 
examination in a field setting11 . 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Summary 
Summary 
 111 
SUMMARY 
                         
 Dengue fever is a vector borne disease which is rapidly spreading in urban 
areas in tropical country like India. The clinical and laboratory findings in dengue are 
very similar to those of other febrile disease that are prevalent in the same 
geographical regions, Therefore, a dengue diagnostic test is required for adequate case 
management.  
¾ This study supports the concept  that  in comparison to IgM and IgG 
antibodies for dengue fever, NS1 antigen assay is an effective tool for 
diagnosis of dengue  infection. 
¾ NS1 antigen assay holds promise particularly in early diagnosis of dengue 
infection when antibodies are not at a detectable level. 
¾  NS1 antigen assay significantly improves the diagnostic algorithm without the 
requirement of paired sera . 
¾ In this study the efficacy of immunochromatographic test in the diagnosis of 
dengue infection is evaluvated by comparing with ELISA , an accepted 
standard test method for dengue diagnosis. 
¾ The   results for NS1 antigen by immunochromatographic test is comparable  
with that of NS1 antigen ELISA . 
¾ In case of IgM and IgG antibody detection , the immunochromatographic test 
method is inferior to ELISA. 
¾ Thrombocytopenia was more observed in NS1 antigen positive cases. 
Viraemia correlates with NS1 positivity and so indirectly correlated with 
thrombocytopenia.  
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                       CONCLUSION 
 
 
1) NS1 antigen detection is a useful tool in the early diagnosis of dengue 
infection and deserves inclusion in the routine diagnostic algorithm of 
suspected dengue fever cases. 
2) Detection of all three parameters NS1 antigen/ IgM , IgG antibodies 
simultaneously gives more information regarding the primary and secondary 
infection. 
3) Rapid immunochromatographic test methods are very useful for early 
diagnosis of dengue infection and case management, where sophisticated 
infrastructure and expertise are scarce. 
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INFORMATION FOR PARTICIPANTS OF THE STUDY 
 
 
 
 
 
 
 
Title of the Study : 
 Detection of NS1 antigen / IgG IgM antibodies in early Dengue Virus infection 
among the patients attending Sree Mookambika Institute of Medical Science, Kulasekharam. 
 
Name of the Investigator : Dr. VIDHYA. V.R. 
 Post Graduate Student 
 Dept of Microbiology 
 SMIMS, Kulasekharam. 
 
Name of the guide :  Dr. N. PALANIAPPAN . M.D 
Professor, Department of Microbiology, 
SMIMS, Kulasekharam. 
 
Name of the Co-guide : Dr. P. Indu (M.D) 
Professor and Head 
Department of Microbiology, 
SMIMS, Kulasekharam. 
 
Institute : Sree Mookambika Institute of Medical Sciences (SMIMS) 
  Kulasekharam, Kanyakumari District, Tamilnadu.                                                                      
Dear Volunteers, 
 We welcome you and thank you for your keen interest in participation in this 
research project. Before you participate in this study, it is important for you to 
understand why this research is being carried out. This form will provide you all the 
relevant details of this research. It will explain the nature, the purpose, the benefits, the 
risks, the discomforts, the precautions and the information about how this project will be 
carried out. It is important that you read and understand the contents of the form 
carefully. This form may contain certain scientific terms and hence, if you have any 
doubts or if you want more information, you are free to ask the study personnel or the 
contact person mentioned below before you give your consent and also at any time 
during the entire course of the project. 
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Introduction : 
Dengue has become a major international public health problem due to human 
morbidity and mortality it cause. Dengue virus is an arthropod borne it causes. Dengue virus 
is an arthropod borne, Flavivirus that can be found in tropical and sub – tropical regions 
world wide. The World Health organization estimates that there may be up to 100 million 
dengue infection world wide which could result up to 250,000 to 500,000 cases of Dengue 
Haemorrhagic Fever each year (Gibbons &  Vaughn, 2002, WHO, 1997). 
The Fever Could Present as 
¾ Mild Dengue fever 
¾ Dengue hemorrhagic fever (DHF) 
¾ Dengue shock syndrome (DSS) 
 
 
Incubation period is 5-11 days. The disease presents as acute febrile illness with 
chills, headache, retro-oculars pain, body aches and arthralgia in more than 90% of apparent 
cases accompanied by nausea, vomiting and a maculopapular rash resembling measles. 
Lasting for 2-7 days. Illness usually persists for 7 days followed with fever remitting after 3-5 
days followed by relapse (saddle – back fever) and pain in the bones muscles and joint to 
earn the name Break – bone fever. 
 
There are 4 serotypes of Dengue designated as DEN 1 through DEN 4.  
 
 
Humans are the main reservoirs for dengue virus. Transmission occurs by mosquito vectors 
that is well adapted to urban setting. Aedes aegypti is the primary vector mosquito for 
Dengue in Western hemispheres. 
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NS1 protein is a 50 Kilda ton glycoprotein that is expressed on the surface of infected 
cells and is found in both secreted and non secreted forms. Dengue NS1 antigen has been 
detected in the serum of DEN virus infected patients as early as one day post onset of 
symptoms (DPO) Upto 18 DPO. 
Procedure for the study : 
 You are required to participate in this study only if you fully understand and agree to 
the requirements for the same. There will be no difference in the treatment you receive, nor 
will treatment be withheld based on your decision to participate in this study. The study is 
done in collaboration with Department of microbiology. Hundred fever patients who 
volunteer are included in this study. After considering inclusion and exclusion criteria.2ml of  
Blood samples will be collected from the fever patients, with fever of duration less than 5 
days. Blood from the OP patients will be collected from the ward and blood from the IP 
patient will be collected from the ward.The test Kit is SD Boiling Dengue. Duo Rapid Test 
Kit which detects the presence of Dengue NS1 Ag on the side and Dengue IgG/ IgM 
antibodies on there side. Your age, address IP No, History of illness will all be taken initially. 
Expected risks for the participants :   Moderate risk 
Expected benefits of research for the participants : 
 Fever could be diagnosed as Dengue fever in its early phase itself. This may help the 
clinician in early diagnosis and treatment of fever cases. If may be graftifying to know that 
your contribution is indispensable for advancement of medical knowledge. 
Confidentiality : 
 All your study records will be kept confidential. Your personal identity will not be 
revealed in any publication or release of results. Study records will be kept indefinitely for 
analysis and follow up. 
Compensation to the participants : NIL 
Can I withdraw from the study at any time during the study period? 
 Yes 
If there is any new findings / information, would I be informed? 
 Yes 
What happens in case of a study related injury? 
 Any adverse event as experienced due to the study will be treated as per hospital 
guidelines. 
 
 
 
 
 
 
 
 
 
 
Place : Kulasekharam      Signature of investigator 
Date : 
For any study related queries, you are free to contact, 
Dr. Vidhya. V.R. 
PG Student 
Department of Microbiology 
SMIMS, Kulasekharam 
Mobile : 918891041013 
amalsnair@gmail.com 
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PART – II 
 The details of the study have been explained to me in writing and the details have 
been fully explained to me. I am aware that the results of the study may not be directly 
beneficial to me but will help in the advancement of medical sciences. I confirm that I have 
understood the study and had the opportunity to ask questions. I understand that my 
participation in the study is voluntary and that I am free to withdraw at any time, without 
giving any reason, without the medical care that will normally be provided by the hospital 
being affected. I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s). I have been given an information sheet 
giving details of the study. I fully consent to participate in the study titled Detection of NSI 
antigen / IgG IgM antibodies in early Dengue virus infection among the patients attending 
SRee Mookambika Institute of Medical Science. 
 
Name :       Address : 
 
 
Hospital No : 
Signature of the participant 
Witness 
1. 
2. 
 
Date : 
Place : Kulasekharam 
PROFORMA 
Sree Mookambika Institute of Medical Science, Kulasekharam 
DEPARTMENT OF MICROBILOGY 
Study Title 
 Detection of NS1 antigen / IgG IgM antibodies in early Dengue virus infection among 
the patients attending Sree Mookambika Institute of Medical Science, Kulasekharam. 
 
- Serial No :     Date : 
- Name : 
- Age : 
- Address : 
 
 
- Contact Number : 
- Hospital reference Numbers : 
- History  of fever duration : 
- Previous history / arthralgia : 
- Previous history of Dengue fever : 
-Platelet count : 
  
